WO1999043644A1 - N-sulphonyl and n-sulphinyl phenylglycinamide___________________ - Google Patents

N-sulphonyl and n-sulphinyl phenylglycinamide___________________ Download PDF

Info

Publication number
WO1999043644A1
WO1999043644A1 PCT/EP1999/001216 EP9901216W WO9943644A1 WO 1999043644 A1 WO1999043644 A1 WO 1999043644A1 EP 9901216 W EP9901216 W EP 9901216W WO 9943644 A1 WO9943644 A1 WO 9943644A1
Authority
WO
WIPO (PCT)
Prior art keywords
phenyl
alkyl
formula
tab
cycloalkyl
Prior art date
Application number
PCT/EP1999/001216
Other languages
French (fr)
Inventor
André Jeanguenat
Martin Zeller
Original Assignee
Novartis Ag
Novartis-Erfindungen Verwaltungsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis-Erfindungen Verwaltungsgesellschaft Mbh filed Critical Novartis Ag
Priority to AT99911707T priority Critical patent/ATE231489T1/en
Priority to JP2000533403A priority patent/JP2002504536A/en
Priority to EP99911707A priority patent/EP1071660B1/en
Priority to AU30302/99A priority patent/AU3030299A/en
Priority to HU0101041A priority patent/HUP0101041A3/en
Priority to CA002320838A priority patent/CA2320838A1/en
Priority to DE69905027T priority patent/DE69905027T2/en
Priority to PL99342620A priority patent/PL342620A1/en
Priority to US09/623,160 priority patent/US6391918B1/en
Priority to BRPI9909239-5A priority patent/BR9909239B1/en
Publication of WO1999043644A1 publication Critical patent/WO1999043644A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A01N41/06—Sulfonic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Definitions

  • the present invention relates to novel ⁇ -amino acid amides of formula I below. It relates to the preparation of those substances and to agrochemical compositions that comprise at least one of those compounds as active ingredient. The invention also relates to the preparation of the said compositions and to the use of the active ingredients or the compositions in the control or prevention of plant infestation by phytopathogenic microorganisms, especially fungi.
  • n is the number zero or one
  • Ri is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl; or a group NR a R wherein R a and R are each independently of the other hydrogen, alkyl or form together an alkylene bridge;
  • R 2 is hydrogen or alkyl
  • R 3 is optionally substituted aryl or heteroaryl
  • A is alkylene
  • alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl or heteroaryl groups may carry one or more identical or different substituents. Normally not more than five substituents in each of these groups are present at the same time.
  • substituents of these groups are : alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl and phenylalkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxyalkyl; haioalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxy; alkoxycarbonyl; alkenyloxycarbonyl; alkynyloxycarbonyl.
  • halogen includes fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine or bromine.
  • alkyl, alkenyl and alkynyl radicals may be straight-chain or branched, this applying also to the alkyl, alkenyl or alkynyl moiety of other groups containing alkyl, alkenyl or alkynyl.
  • alkyl on its own or as part of another substituent is to be understood as meaning, for example, methyl, ethyl, propyl, butyl, pentyl, n-hexyl, n-heptyl, n-octyl, n-decyl, n-dodecyl and the isomers thereof, such as isopropyl, isobutyl, tert-butyl, sec-butyl, tert-amyl, 1 -ethyl-hexyl, n-octyl, n-nonyl or n-decyl.
  • Cycloalkyl denotes, depending on the number of carbon atoms mentioned, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
  • Alkenyl will be understood as meaning straight-chain or branched alkenyl such as allyl, vinyl, methallyl, 1-methylvinyl, but-2-en-1-yl, pent-2-en-1-yl or hex-2-en-1 -yl.
  • Preferred alkenyl radicals contain 3 to 4 carbon atoms in the chain.
  • Alkynyl can likewise, in accordance with the number of carbon atoms, be straight-chain or branched and is typically propargyl, but-2-yl-1 -yl, but-1-yn-3-yl, pent-2-yn-1 -yl or hex-2-yn-1 -yl.
  • the preferred meaning is propargyl.
  • a haloalkyl group may have one or more (identical or different) halogen atoms, such as, for example, CHCl 2 , CH 2 F, CCI 3 , CCIF 2 , CH 2 Cl, CHF 2 , CF 3) CH 2 CH 2 Br, CH 2 CF 3 , CH 2 CH 2 F, C 2 CI 5 , CH 2 Br, CHBrCI, CH 2 CH 2 CF 3 etc.
  • Alkoxy is typically methoxy, ethoxy, propyloxy, isopropyloxy, n-butyloxy, isobutyloxy, sec-butyloxy and tert-butyloxy. Methoxy and ethoxy are preferred.
  • Alkylthio is typically methylthio or ethylthio.
  • Haloalkoxy is any alkoxy substituted with one or more halogen atoms. Typical examples are difluoromethoxy, trifluoromethoxy, 2,2,-trifluoroethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy and 2,2-difluoroethoxy.
  • Aryl can be for example phenyl or naphthyl.
  • Arylalkyl can be for example benzyl, 2-phenyl-ethyl or 3-phenyl-propyl.
  • Heteroaryl stands for aromatic ring systems comprising mono-, bi- or tricyclic systems wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member.
  • Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indoiyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotriazolyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quinoxaliny
  • Alkanoyl is, in accordance with the number of carbon atoms embraced, either straight-chain or branched. Typical examples are formyl, acetyl, propionyl, butyryl or pivaloyl.
  • Formula I is intended to encompass all of those possible isomeric forms and mixtures thereof.
  • Ri is d-C ⁇ al-kyl, C -C 10 alkenyl, C 2 -C ⁇ 0 alkynyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyl-Ci-C 6 alkyl,
  • R 3 is phenyl, naphthyi or heteroaryl formed by 1 or 2 five- or six-membered rings containing 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur and are optionally mono- or poly-substituted by CrC 8 alkyl, C 2 -C 8 alkenyl, C -C 8 alkynyl, CrC ⁇ alkoxy, CrC ⁇ alkylthio, C ⁇ -C 8 alkylsulfonyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyl-CrC 6 alkyl, C ⁇ -C 4 alkylendioxy, CrC 8 alkoxycarbonyl, C 3 -C 8 alkenyloxycarbonyl, C 3 -C 8 alkynyloxycarbonyl, C 3 -C 8 cycloalkyloxy, C -C 8 alkenyloxy, C 3 -C 8 alkynyloxycarbonyl, C 3
  • B is phenyl optionally mono- or poly-substituted by C C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, CrC ⁇ alkoxy, CrC ⁇ alkylthio, CrC 8 alkylsulfonyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycioalkyl-CrC 6 alkyl, CrC 8 alkoxycarbonyl, C 3 -C 8 alkenyloxycarbonyl, C 3 -C 8 alkynyloxycarbonyl, C 3 -C 8 cycloalkyloxy, C 3 -C 8 alkenyloxy, C 3 -C 8 alkynyloxy, CrC 8 alkanoyl, CrC 8 dialkylamino, CrC 8 alkylamino, C 6 -C ⁇ 0 aryloxy, C 6 -C 10 aryl-CrC 6 alkoxy, Ce
  • R is CrC ⁇ 0 alkyl C 2 -C 10 alkenyl, C 3 -C 8 cycloalkyl that are optionally mono- or poly-substituted by CrC 8 alkyl, CrC 8 alkoxy, CrC 8 alkylthio, CrC 8 alkanoyl, CrC 8 alkoxycarbonyl, - 5 -
  • R 3 is phenyl, naphthyi, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, pyridyl, pyrimidinyl, benzothiophenyl, benzothiazolyl, chinolinyl, pyrazolyl, indolyl, benzimidazolyl or pyrrolyl optionally substituted by 1 to 3 substituents selected from CrC 8 alkyl, C 2 -C 8 alkenyl, C 3 -C 8 cycloalkyl, CrC 8 alkoxy, CrC 8 alkylthio, CrC 8 alkoxycarbonyl, CrC ⁇ halogenalkyI, d-C ⁇ halogenalkoxy, CrC 8 halogenalkylthio, halogen, hydroxy, nitro or cyano; A is C C 4 alkylen; and
  • B is phenyl optionally substituted by 1 to 3 substituents selected from CrC 8 alkyl, CrC 8 alkoxy, C 3 -C 8 alkenyloxy, C 3 -C 8 alkynyloxy, phenyl-CrC 6 alkyloxy, phenyl-C 3 - C 6 alkenyloxy, phenyl-C 3 -C 6 alkynyloxy, C C 8 alkylthio, CrC 8 alkoxycarbonyl, CrCahalogenalkoxy, C 3 -C 8 halogenalkenyloxy, halogen, hydoxy, nitro or cyano (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from CrC 8 alkyl, C C 8 alkoxy, CrC 8 alkylthio, CrC 8 halogenalkyl, CrC 8 halogenalkoxy, C ⁇ -C 8 halogenthioalkyl, halogen or cyan
  • Ri is CrC 6 alkyl, C 2 -C ⁇ 0 alkenyl, C 5 -C 6 cycloalkyl, that are optionally mono- or poly-substituted by CrC 8 alkyl, CrC 8 alkoxy, C C 8 alkoxycarbonyl, C C 8 halogenalkyl, CrC 8 halogenalkoxy, halogen or cyano; or a group NR a R b , wherein R a and R b are each independently of the other methyl or ethyl;
  • R 2 is hydrogen
  • R 3 is phenyl optionally substituted by 1 to 3 substituents selected from CrC 8 alkyl,
  • A is ethylen
  • B is phenyl optionally substituted by 2 to 3 substituents selected from d-C 8 alkyl, d-C 8 alkoxy, C 3 -C 8 alkenyloxy, C 3 -C 8 alkynyloxy, phenyl-CrC 6 alkyloxy, phenyl-C 3 -
  • a special group within the scope of sub-group C comprises compounds of formula I wherein n is the number one;
  • R is d-dalkyl optionally mono- or poly-substituted by fluorine, chlorine, bromine or dimethylamin;
  • R 2 is hydrogen
  • R 3 is phenyl optionally substituted by 1 to 3 substituents selected from d-C 8 alkyl,
  • A is ethylen
  • R 8 is d-dalkyl
  • R 9 is d-C 8 alkyl, C 3 -C 8 alkenyl, C 3 -C 8 alkynyl, phenyl-CrC 6 alkyl, phenyl-C 3 -C 6 alkenyl, phenyl-
  • Step B H 2 N- -A- -B V
  • Step B An amino acid of formula II or a carboxy-activated derivative of an amino acid of formula II, where Ri, n, R 2 and R 3 have the meaning as defined above, is reacted with an amine of the formula V where A and B have the meaning as defined above, optionally in the presence of a base and optionally in the presence of a diluting agent.
  • carboxy-activated derivatives are suitable as carboxy-activated derivatives of the amino acid of formula II, such as acid halides, for example acid chlorides or fluorides; symmetrical or mixed anhydrides, for example the mixed O-alkylcarboxylic acid anhydrides; activated esters, for example p-nitrophenyl esters or N-hydroxysuccinimide esters, and activated forms of the amino acid II produced in situ using condensation agents (e.g.
  • dicyclohexylcarbodiimide carbonyldiimidazole, 0-(benzotriaz-1 -yl)-N,N,N',N'- bis(pentamethylene)uronium hexafluorophosphate, 0-(benzotriaz-1 -yl)-N,N,N',N'- bis(tetramethylene)uronium hexafluorophosphate, (benzotriazol-1 -yloxy)- tripyrrolidinophosphonium hexafluorophosphate, (benzotriazol-1 -yloxy)- tris(dimethylamino)phosphonium hexafluorophosphate or 0-(benzotriazol-1 -yl)-N,N,N',N'- tetramethyluronium hexafluorophosphate).
  • the acid halides corresponding to the amino acid of formula II can be prepared by reacting the amino acid of formula II in a manner known perse with a halogenating agent, for example phosphorus pentachloride, thionyl chloride, oxalyl chloride, cyanuric fluoride or diethylaminosulfur trifluoride.
  • a halogenating agent for example phosphorus pentachloride, thionyl chloride, oxalyl chloride, cyanuric fluoride or diethylaminosulfur trifluoride.
  • the mixed anhydrides corresponding to the amino acid of formula II can be prepared by reacting the amino acid of formula II with chloroformic acid esters, for example chloroformic acid alkyl esters, preferably chloroformic acid isobutyl ester, in the absence or presence of an acid-binding agent, such as an inorganic or organic base, for example a tertiary amine, e.g. triethylamine, pyridine, N-methylpiperidine or N-methylmorpholine.
  • chloroformic acid esters for example chloroformic acid alkyl esters, preferably chloroformic acid isobutyl ester
  • an acid-binding agent such as an inorganic or organic base, for example a tertiary amine, e.g. triethylamine, pyridine, N-methylpiperidine or N-methylmorpholine.
  • Step A The compounds of formula II can be prepared by reaction of an amino acid of formula IV where R 2 and R 3 have the same meanings as defined above with a sulfonyl halide or a sulfinyl halide of formula III where Ri and n have the meanings as defined above and where X is halide, preferentially chlorine or bromine.
  • the reaction is optionally performed in a solvent and in presence of a base.
  • Step C The compounds of formula I can also be prepared by reaction of an amino acid derivative of formula VI where R 2 , R 3 , A and B have the same meanings as defined above with a sulfonyl halide or a sulfinyl halide of formula III where Ri and n have the same meanings as defined above and where X is halide, preferentially chlorine or bromine. The reaction is performed in the same manner as described for step A.
  • organic oxidizing agents such as alkyl hydroperoxides, for example cumyl hydroperoxide
  • inorganic oxidizing agents such as peroxides, for example hydrogen peroxide, or transition metal oxides, for example chromium trioxide, and transition metal oxide salts, for example potassium permanganate, potassium or sodium dichromate, are suitable oxidizing agents.
  • reaction of the compounds of formula I' with the oxidizing agents takes place in an inert diluent, such as water or a ketone, for example acetone, or in mixtures thereof, in the absence or presence of an acid or in the absence or presence of a base, at temperatures of from -80 to +150°C. - 9 -
  • the compounds of formula VI can be prepared by the following process d)
  • Step D An isocyanide of formula VII, where A and B are as defined before (see D.Seebach, G.Adam, T.Gees, M.Schiess, W.Weigang, Chem.Ber., 1988, 121 ,507) is reacted with a known compound of formula VIII (R 2 and R 3 are as defined before), a known compound of formula IX (R ⁇ 0 is lower alkyl or H) and ammonia in a solvent (typically an alcohol as methanol or ethanol, tetrahydrofuran, methylenchloride) at a temperature between -20° and +150°C, optionally in the presence of a Lewis acid, typically ZnCI 2 (Ugi reaction).
  • a solvent typically an alcohol as methanol or ethanol, tetrahydrofuran, methylenchloride
  • Step E A compound of formula X, where R 2 , R 3 , R ⁇ 0 , A and B are as defined before, is hydrolysed under acidic or basic conditions at a temperature between 0° and 100°C.
  • Typical acids are mineral acids as HCI, H 2 S0 4 , organic acids as p-toluenesulfonic acid, methanesulfonic acid, trifluoroacetic acid;
  • typical bases are NaOH, KOH, Ba(OH) 2 , carbonates, triethylamine, ethyl diisopropylamine;
  • typical solvents are alcohols like ethanol or methanol, tetrahydrofurane, dimethylformamide, dimethylsulfoxide.
  • Compound VI can be converted to compounds of formula I by step C as described under process b).
  • the invention relates also to the amino acid derivatives of formula VI, wherein R 2 , R 3 , A and B have the meaning as defined for formula I. - 10 -
  • the sulfonic acid or sulfinic acid or the sulfonic or sulfinic acid derivative of formula III required for process a) or b) and the amino acids of formula IV required for process a) are known per se.
  • Suitable sulfonic or sulfinic acid derivatives of formula III are any compounds wherein Z is a leaving group, such as sulfonic acid halides or sulfinic acid halides, e.g. sulfochlorides or sulfinic acid chlorides; symmetrical or mixed anhydrides; and activated forms of sulfonic acid or sulfinic acid produced in situ using condensation agents, such as dicyclohexyl- carbodiimide or carbonyldiimidazole.
  • Z is a leaving group, such as sulfonic acid halides or sulfinic acid halides, e.g. sulfochlorides or sulfinic acid chlorides; symmetrical or mixed anhydrides; and activated forms of sulfonic acid or sulfinic acid produced in situ using condensation agents, such as dicyclohexyl- carbodiimide or carbonyldiimidazole.
  • compounds of formula I have for practical purposes a very advantageous biocidal spectrum in the control of phytopathogenic microorganisms, especially fungi. They possess very advantageous curative and preventive properties and are used in the protection of numerous crop plants. With the compounds of formula I it is possible to inhibit or destroy pests occurring on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later, for example, also remain protected against phytopathogenic fungi.
  • the novel compounds of formula I prove to be preferentially effective against specific genera of the fungus class Fungi imperfecti (e.g. Cercospora), Basidiomycetes (e.g.
  • Puccinia and Ascomycetes (e.g. Erysiphe and Venturia) and especially against Oomycetes (e.g. Plasmopara, Peronospora, Bremia, Pythium, Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phytopathogenic fungi.
  • the compounds of formula I can also be used as dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phytopathogenic fungi that occur in the soil.
  • the invention relates also to compositions comprising compounds of formula I as active ingredients, especially plant-protecting compositions, and to the use thereof in the agricultural sector or related fields.
  • the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances herein described. Also included is a method for the treatment of plants which comprises applying the novel compounds of formula I or the novel compositions. - 11 -
  • Target crops to be protected within the scope of this invention comprise, for example, the following species of plants: cereals (wheat, barley, rye, oats, rice, maize, sorghum, spelt, triticale and related species); beet (sugar beet and fodder beet); pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas and soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans and groundnuts); cucumber plants (marrows, cucumbers and melons); fibre plants (cotton, flax, hemp and jute); citrus fruit (oranges, lemons, grapefruit and mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika); lauraceae (avocados, cinnamon and camphor) and
  • the compounds of formula I are normally applied in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with further active ingredients.
  • Those further active ingredients may be fertilizers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides, and insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application- promoting adjuvants customarily employed in formulation technology.
  • Suitable carriers and adjuvants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binding agents or fertilizers. Such carriers are for example described in WO 97/33890.
  • a preferred method of applying a compound of formula I, or an agrochemical composition comprising at least one of those compounds, is application to the foliage of the plants (foliar application), the frequency and the rate of application depending upon the risk of infestation by the pathogen in question.
  • the compounds of formula I may also be applied to propagation material (grains, fruits, tubers, shoots, cuttings, roots etc.) (dressing), for example either by impregnating cereal grains (seeds) or potato tubers or freshly cut shoots with a liquid formulation of the active ingredient or by coating them with a solid formulation.
  • the compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e.g into emulsifiable concentrates, coatable pastes, directly sprayable or dilutabie solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and also encapsulations in e g. polymer substances.
  • the methods of application such as spraying, atomizing, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
  • Advantageous rates of application are normally from 1 g to 2kg of active ingredient (a.i.) per hectare, preferably from 10g to 1 kg a.i./ha, especially from 25g to 750g a.i./ha
  • rates of from 0.001 g to 1.0g of active ingredient per kg of seed are advantageously used
  • compositions, preparations or mixtures comprising the compound (active ingredient) of formula I and, where appropriate, a solid or liquid adjuvant are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredient with extenders, e.g. solvents, solid carriers and, where appropriate, surface- active compounds (surfactants).
  • extenders e.g. solvents, solid carriers and, where appropriate, surface- active compounds (surfactants).
  • the compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.
  • azoles such as azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutnafol, hexaconazole, imazaltl, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pynfenox, prochloraz, propiconazole, tebuconazole, tetraconazole, t ⁇ adimefon, tnadimenol, t ⁇ flumizole or tnticonazole; py ⁇ midinyl carbinoles such as ancymidol.fenarimol or nuanmol; 2-am ⁇ no-pyr ⁇ m ⁇ d ⁇ n
  • dicarboximides such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone or vinclozolin; carboxamides such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin or thifluzamide; guanidines such as guazatine, dodine or iminoctadine; strobilurines such as azoxystrobin, kresoxim-methyl, metominostrobin, SSF-129, 2-[(2-trifluoromethyl)-pyrid-6- yloxymethyl]-3-methoxyacrylate or 2-[ ⁇ [( ⁇ -methyl-3-trifluoromethyl-benzyl)imino]-oxy ⁇ -o- tolylj-giyoxylic acid-methylester-O-methyloxime; dithiocarbamates such as ferbam, mancozeb, maneb, metiram, propineb, thiram,
  • the agrochemical compositions usually comprise 0.1 to 99% by weight, preferably 0.1 to 95% by weight, of a compound of formula I, 99.9 to 1 % by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and 0 to 25% by weight, preferably 0.1 to 25% by weight, of a surfactant.
  • Ri is methyl and n is the number one and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 2 Compounds of formula 1.1 wherein Ri is ethyl and n is the number one and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 3 Compounds of formula 1.1 wherein Ri is ethyl and n is zero and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 4 Compounds of formula 1.1 wherein Ri is propyl and n is the number one and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 5 Compounds of formula 1.1 wherein Ri is propyl and n is zero and where the combination of R , R 3 , A and B corresponds to one line in Table A.
  • Table 6 Compounds of formula 1.1 wherein R, is isopropyl and n is the number one and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 7 Compounds of formula 1.1 wherein Ri is isopropyl and n is zero and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 8 Compounds of formula 1.1 wherein Ri is butyl and n is the number one and where the combination of R 2) R 3 , A and B corresponds to one line in Table A. - 15 -
  • Table 9 Compounds of formula 1.1 wherein Ri is butyl and n is zero and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • a and B corresponds to one line in Table A.
  • a and B corresponds to one line in Table A.
  • Table 12 Compounds of formula 1.1 wherein Ri is phenyl and n is the number one and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • Table 13 Compounds of formula 1.1 wherein Ri is benzyl and n is the number one and where the combination of R 2 , R 3 , A and B corresponds to one line in Table A.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R is hydrogen and where the combination of R 1 t R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 f R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R ⁇ R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R., R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R,, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 f R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 t R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • Table 33 Compounds of formula 1.21 O R, .o OCH 3 R — s — NH . CH, (1.21) 1 II (0) n R, NH — CH- -CH; 0 °A wherein R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 ( R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 ( R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 t R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 f R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R ⁇ R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B. - 23
  • R 2 is hydrogen and where the combination of R 1 ( R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B. - 24 -
  • R is hydrogen and where the combination of R 1 ( R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R ⁇ ,, R 3 and n corresponds to one line in Table B.
  • R is hydrogen and where the combination of R*,, R 3 and n corresponds to one line in Table B.
  • R 2 is hydrogen and where the combination of R 1 t R 3 and n corresponds to one line in Table B. 25
  • A.68 H 4-CI-phenyl -CH 2 - 2,4-di-CI-phenyl
  • A.206 H 4-Br-phenyl -CH(CH 3 )- 3-OCH 3 -4-SCH 3 -phenyl
  • A.207 H 4-CF 3 -phenyl -CH 2 CH 2 - phenyl
  • A.216 H 4-CF 3 -phenyl -CH(CH 3 )- 4-CH 3 -phenyl
  • A.220 H 4-CF 3 -phenyl -CH(CH 3 )- 3-OCH 3 -4-SCH 3 -phenyl
  • A.221 H 4-CH 3 -phenyl -CH 2 CH 2 - phenyl
  • A.223 H 4-CH 3 -phenyl -CH 2 CH 2 - 4-CH 3 -phenyl
  • A.226 H 4-CH 3 -phenyl -CH 2 CH 2 - 3-OCH 3 -4-phenoxy-phenyl
  • the organic phase is separated and extracted with 100 ml 2N sodium hydroxide solution.
  • the water phases are combined and acidified with cone, hydrochloric acid to pH ⁇ 2 and extracted with ethyl acetate (2x500 ml).
  • the organic phases are washed with brine solution (2x150 ml), dried over magnesium sulfate and evaporated to dryness, yielding (4-chloro- phenyl)-ethanesulfonamino-acetic acid as yellow oil.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

Novel α-amino acid amides of formula (I) as well as possible isomers and mixtures of isomers thereof, wherein the substituents are defined as follows: n is the number zero or one; R1 is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl; or a group NRaRb wherein Ra and Rb are each independently of the other hydrogen, alkyl or form together an alkylene bridge; R2 is hydrogen or alkyl; R3 is optionally substituted aryl or heteroaryl; A is alkylene; and B is optionally substituted aryl; with the exception of the following compounds 2-phenyl-N- (1-phenyl-ethyl)- 2-(4-methylphenyl)- sulfonylamino-acetamide, 2-phenyl- N-(1-phenyl-ethyl)- 2-(4-chlorophenyl)- sulfonylamino-acetamide, 2-phenyl- N-(1-phenyl-ethyl)- 2-(4-nitrolphenyl)- sulfonylamino-acetamide, 2-phenyl- N-(1-phenyl-ethyl)- 2-(4-methoxyphenyl)- sulfonylamino-acetamide, 2-phenyl- N-(1-phenyl-ethyl)- 2-(4-fluorophenyl)- sulfonylamino-acetamide, 2-phenyl- N-(1-phenyl-ethyl)- 2-phenyl-sulfonylamino- acetamide and 2-phenyl-N-(1-phenyl-ethyl)-2-methane-sulfonylamino-acetamide. The novel compounds have plant-protective properties and are suitable for protecting plants against infestations by phytopathogenic microorganisms, in particular fungi.

Description

- 1 -
N-SULPHONYL and N-SULPHINYL PHENYLGLYCINAMIDE
The present invention relates to novel α-amino acid amides of formula I below. It relates to the preparation of those substances and to agrochemical compositions that comprise at least one of those compounds as active ingredient. The invention also relates to the preparation of the said compositions and to the use of the active ingredients or the compositions in the control or prevention of plant infestation by phytopathogenic microorganisms, especially fungi.
The compounds according to the invention correspond to the general formula I
O
R ■NH- f (l)
(O)n 3 NH-A — B
as well as possible isomers and mixtures of isomers thereof, wherein the substituents are defined as follows: n is the number zero or one;
Ri is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl; or a group NRaR wherein Ra and R are each independently of the other hydrogen, alkyl or form together an alkylene bridge;
R2 is hydrogen or alkyl;
R3 is optionally substituted aryl or heteroaryl;
A is alkylene; and
B is optionally substituted aryl; with the exception of the following compounds
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-methylphenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-chlorophenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-nitrophenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-methoxyphenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-fluorophenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-phenyl-sulfonylamino-acetamide and
2-phenyl-N-(1 -phenyl-ethyl)-2-methane-sulfonylamino-acetamide. - 2 -
The above alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl or heteroaryl groups may carry one or more identical or different substituents. Normally not more than five substituents in each of these groups are present at the same time. Examples of substituents of these groups are : alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl and phenylalkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxyalkyl; haioalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxy; alkoxycarbonyl; alkenyloxycarbonyl; alkynyloxycarbonyl.
In the above formula I, "halogen" includes fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine or bromine.
The alkyl, alkenyl and alkynyl radicals may be straight-chain or branched, this applying also to the alkyl, alkenyl or alkynyl moiety of other groups containing alkyl, alkenyl or alkynyl.
Depending on the number of carbon atoms mentioned, alkyl on its own or as part of another substituent is to be understood as meaning, for example, methyl, ethyl, propyl, butyl, pentyl, n-hexyl, n-heptyl, n-octyl, n-decyl, n-dodecyl and the isomers thereof, such as isopropyl, isobutyl, tert-butyl, sec-butyl, tert-amyl, 1 -ethyl-hexyl, n-octyl, n-nonyl or n-decyl. Cycloalkyl denotes, depending on the number of carbon atoms mentioned, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
Alkenyl will be understood as meaning straight-chain or branched alkenyl such as allyl, vinyl, methallyl, 1-methylvinyl, but-2-en-1-yl, pent-2-en-1-yl or hex-2-en-1 -yl. Preferred alkenyl radicals contain 3 to 4 carbon atoms in the chain.
Alkynyl can likewise, in accordance with the number of carbon atoms, be straight-chain or branched and is typically propargyl, but-2-yl-1 -yl, but-1-yn-3-yl, pent-2-yn-1 -yl or hex-2-yn-1 -yl. The preferred meaning is propargyl.
A haloalkyl group may have one or more (identical or different) halogen atoms, such as, for example, CHCl2, CH2F, CCI3, CCIF2, CH2Cl, CHF2, CF3) CH2CH2Br, CH2CF3, CH2CH2F, C2CI5, CH2Br, CHBrCI, CH2CH2CF3 etc.. Alkoxy is typically methoxy, ethoxy, propyloxy, isopropyloxy, n-butyloxy, isobutyloxy, sec-butyloxy and tert-butyloxy. Methoxy and ethoxy are preferred.
Alkylthio is typically methylthio or ethylthio.
Haloalkoxy is any alkoxy substituted with one or more halogen atoms. Typical examples are difluoromethoxy, trifluoromethoxy, 2,2,-trifluoroethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy and 2,2-difluoroethoxy.
Aryl can be for example phenyl or naphthyl.
Arylalkyl can be for example benzyl, 2-phenyl-ethyl or 3-phenyl-propyl.
Heteroaryl stands for aromatic ring systems comprising mono-, bi- or tricyclic systems wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member. Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indoiyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotriazolyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quinoxalinyl, quinazolinyl, cinnolinyl and naphthyridinyl.
Alkanoyl is, in accordance with the number of carbon atoms embraced, either straight-chain or branched. Typical examples are formyl, acetyl, propionyl, butyryl or pivaloyl.
As a result of the presence of at least one asymmetric carbon atom and/or at least one asymmetric sulfur atom in the compounds of formula I the compounds may occur in the form of optical isomers. Owing to the presence of an aliphatic -C=C- double bond, geometrical isomerism may also occur. Formula I is intended to encompass all of those possible isomeric forms and mixtures thereof.
Preference is given to compounds of formula I wherein n is the number zero or one;
Ri is d-C^al-kyl, C -C10alkenyl, C2-Cι0alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-Ci-C6alkyl,
C6-C10aryl, or C6-C10aryl-Ci-C6alkyl that are optionally mono- or poly-substituted by - 4 -
CrCβalkyl, CrC8alkoxy, d-Cβalkylthio, CrC8alkyisulfonyl, C3-C8cycloalkyl, CrC8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C3-C8cycloalkyl- Cι-C6alkyl, C -C8alkenyl, C2-C8alkynyl, C3-C8alkenyloxy, C3-C8alkynyloxy, Cι-C8alkanoyl (where all these alkyl, alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated), halogen, cyano or nitro; or a group NRaRb> wherein Ra and Rb are each independently of the other hydrogen, d-C8alkyl or together are C2-C7alkylen; R2 is hydrogen or d-C8alkyl;
R3 is phenyl, naphthyi or heteroaryl formed by 1 or 2 five- or six-membered rings containing 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur and are optionally mono- or poly-substituted by CrC8alkyl, C2-C8alkenyl, C -C8alkynyl, CrCβalkoxy, CrCβalkylthio, Cι-C8alkylsulfonyl, C3-C8cycloalkyl, C3-C8cycloalkyl-CrC6alkyl, Cι-C4alkylendioxy, CrC8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C3-C8cycloalkyloxy, C -C8alkenyloxy, C3-C8alkynyloxy, CrC8alkanoyl, CrC8dialkylamino, Cι-C8alkylamino (where all these alkyl alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated), halogen, nitro, cyano, hydroxy or amino; A is Cι-C8alkylen; and
B is phenyl optionally mono- or poly-substituted by C C8alkyl, C2-C8alkenyl, C2-C8alkynyl, CrCβalkoxy, CrCβalkylthio, CrC8alkylsulfonyl, C3-C8cycloalkyl, C3-C8cycioalkyl-CrC6alkyl, CrC8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C3-C8cycloalkyloxy, C3-C8alkenyloxy, C3-C8alkynyloxy, CrC8alkanoyl, CrC8dialkylamino, CrC8alkylamino, C6-Cι0aryloxy, C6-C10aryl-CrC6alkoxy, Ce-Cioaryl-d-Cealkenyloxy, Ce-C^aryl-CrCealkynyloxy, CrC8alkanoyloxy (where all these alkyl alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated and where all aryl containing groups may be optionally mono- or poly-substituted by C C8alkyl, C2-C8alkenyl C3-C8cycloalkyl, CrC8alkoxy, CrC8alkylthio, C C8alkoxycarbonyl C C8halogenalkyl, CrC8halogenalkoxy, CrC8halogenthioalkyl, halogen nitro or cyano), halogen, nitro, cyano, hydroxy, amino or the phenyl group may be substituted in two adjacent positions by CrC4alkylenedioxy wherein the alkylene part may be substituted by halogen (sub-group A).
Within the scope of sub-group A, special mention should be made of those compounds of formula I wherein n is the number zero or one;
R, is CrCι0alkyl C2-C10alkenyl, C3-C8cycloalkyl that are optionally mono- or poly-substituted by CrC8alkyl, CrC8alkoxy, CrC8alkylthio, CrC8alkanoyl, CrC8alkoxycarbonyl, - 5 -
CrC8halogenalkyl, CrC8halogenalkoxy, CrC8halogenalkylthio, halogen, nitro or cyano; or a group NRaRb, wherein Ra and Rb are each independently of the other hydrogen, CrC8alkyl, or together are tetramethylene or pentamethylene; R2 is hydrogen or methyl;
R3 is phenyl, naphthyi, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, pyridyl, pyrimidinyl, benzothiophenyl, benzothiazolyl, chinolinyl, pyrazolyl, indolyl, benzimidazolyl or pyrrolyl optionally substituted by 1 to 3 substituents selected from CrC8alkyl, C2-C8alkenyl, C3-C8cycloalkyl, CrC8alkoxy, CrC8alkylthio, CrC8alkoxycarbonyl, CrCβhalogenalkyI, d-Cβhalogenalkoxy, CrC8halogenalkylthio, halogen, hydroxy, nitro or cyano; A is C C4alkylen; and
B is phenyl optionally substituted by 1 to 3 substituents selected from CrC8alkyl, CrC8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, phenyl-CrC6alkyloxy, phenyl-C3- C6alkenyloxy, phenyl-C3-C6alkynyloxy, C C8alkylthio, CrC8alkoxycarbonyl, CrCahalogenalkoxy, C3-C8halogenalkenyloxy, halogen, hydoxy, nitro or cyano (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from CrC8alkyl, C C8alkoxy, CrC8alkylthio, CrC8halogenalkyl, CrC8halogenalkoxy, Cι-C8halogenthioalkyl, halogen or cyano) (sub-group B).
An important group is formed by compounds of formula I wherein n is the number one;
Ri is CrC6alkyl, C2-Cι0alkenyl, C5-C6cycloalkyl, that are optionally mono- or poly-substituted by CrC8alkyl, CrC8alkoxy, C C8alkoxycarbonyl, C C8halogenalkyl, CrC8halogenalkoxy, halogen or cyano; or a group NRaRb, wherein Ra and Rb are each independently of the other methyl or ethyl;
R2 is hydrogen;
R3 is phenyl optionally substituted by 1 to 3 substituents selected from CrC8alkyl,
C2-C8alkenyl, C3-C8cycloalkyl, CrC8alkoxy, CrC8alkylthio, CrC8alkoxycarbonyl, d-Cahalogenalkyl, CrC8halogenalkoxy, d-C8halogenthioalkyl, halogen, hydroxy, nitro or cyano;
A is ethylen; and
B is phenyl optionally substituted by 2 to 3 substituents selected from d-C8alkyl, d-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, phenyl-CrC6alkyloxy, phenyl-C3-
C6alkenyloxy, phenyl-C3-C6alkynyloxy, d-C8alkylthio, CrC8alkoxycarbonyl, d-Cshalogenalkoxy, C3-C8halogenalkenyloxy, halogen, hydroxy, nitro or cyano (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from d-C8alkyl, d-C8alkoxy, d-C8alkylthio, CrC8halogenalkyl, d-C8halogenalkoxy, d-Cshalogenthioalkyl, halogen or cyano) (sub-group C).
A special group within the scope of sub-group C comprises compounds of formula I wherein n is the number one;
R, is d-dalkyl optionally mono- or poly-substituted by fluorine, chlorine, bromine or dimethylamin;
R2 is hydrogen;
R3 is phenyl optionally substituted by 1 to 3 substituents selected from d-C8alkyl,
C -C8alkenyl, C3-C8cycloalkyl, d-C8alkoxy, CrC8alkylthio, d-C8alkoxycarbonyl, d-C8halogenalkyl, CrC8halogenalkoxy, C C8halogenthioalkyl, halogen, nitro or cyano;
A is ethylen; and
B is a group
Figure imgf000008_0001
0-R0
wherein
R8 is d-dalkyl, and
R9 is d-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, phenyl-CrC6alkyl, phenyl-C3-C6alkenyl, phenyl-
C3-C6alkynyl, d-C8halogenalkyl, C3-C8halogenalkenyl (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from d-C8alkyl, d-C8alkoxy,
CrC8alkylthio, d-C8halogenalkyl, d-C8halogenalkoxy, CrC8halogenthioalkyl, halogen or cyano) (sub-group Ca).
Certain α-amino acid derivatives having a different kind of structure have already been proposed for the control of plant-destructive fungi (for example in EP-398 072, EP-425925, DE-40 26 966, EP-477 639, EP-493 683, DE-40 35 851 , EP-487 154, EP-496239, EP-550 788 and EP-554729). Those compositions are not, however, satisfactory in their action. Surprisingly, with the compound structure of formula I, new kinds of microbicides having a high activity have been found. - 7 -
Description of the process for the preparation of compounds according to the invention The compounds of formula I can be prepared by one of the following processes : a)
O R, R,
II
R -s— X H-N- -COOH R, — S- NH- -COOH step A II
R, (O)n R,
III IV
Step B H2N- -A- -B V
O R o II R, — S — NH- J K
(°)n R π3 NH-A-B
Step B: An amino acid of formula II or a carboxy-activated derivative of an amino acid of formula II, where Ri, n, R2 and R3 have the meaning as defined above, is reacted with an amine of the formula V where A and B have the meaning as defined above, optionally in the presence of a base and optionally in the presence of a diluting agent. Any carboxy-activated derivatives are suitable as carboxy-activated derivatives of the amino acid of formula II, such as acid halides, for example acid chlorides or fluorides; symmetrical or mixed anhydrides, for example the mixed O-alkylcarboxylic acid anhydrides; activated esters, for example p-nitrophenyl esters or N-hydroxysuccinimide esters, and activated forms of the amino acid II produced in situ using condensation agents (e.g. dicyclohexylcarbodiimide, carbonyldiimidazole, 0-(benzotriaz-1 -yl)-N,N,N',N'- bis(pentamethylene)uronium hexafluorophosphate, 0-(benzotriaz-1 -yl)-N,N,N',N'- bis(tetramethylene)uronium hexafluorophosphate, (benzotriazol-1 -yloxy)- tripyrrolidinophosphonium hexafluorophosphate, (benzotriazol-1 -yloxy)- tris(dimethylamino)phosphonium hexafluorophosphate or 0-(benzotriazol-1 -yl)-N,N,N',N'- tetramethyluronium hexafluorophosphate).
The acid halides corresponding to the amino acid of formula II can be prepared by reacting the amino acid of formula II in a manner known perse with a halogenating agent, for example phosphorus pentachloride, thionyl chloride, oxalyl chloride, cyanuric fluoride or diethylaminosulfur trifluoride. - 8 -
The mixed anhydrides corresponding to the amino acid of formula II can be prepared by reacting the amino acid of formula II with chloroformic acid esters, for example chloroformic acid alkyl esters, preferably chloroformic acid isobutyl ester, in the absence or presence of an acid-binding agent, such as an inorganic or organic base, for example a tertiary amine, e.g. triethylamine, pyridine, N-methylpiperidine or N-methylmorpholine.
Step A: The compounds of formula II can be prepared by reaction of an amino acid of formula IV where R2 and R3 have the same meanings as defined above with a sulfonyl halide or a sulfinyl halide of formula III where Ri and n have the meanings as defined above and where X is halide, preferentially chlorine or bromine. The reaction is optionally performed in a solvent and in presence of a base.
b)
9 ?2 9 II 2 ,o
R,— s— x H2N J/ R, — S M NuHJ 0
Qton r. '1 II
(0)n R3 NH-A-B Step C (ό)n R3 NH-A-B
III VI I
Step C: The compounds of formula I can also be prepared by reaction of an amino acid derivative of formula VI where R2, R3, A and B have the same meanings as defined above with a sulfonyl halide or a sulfinyl halide of formula III where Ri and n have the same meanings as defined above and where X is halide, preferentially chlorine or bromine. The reaction is performed in the same manner as described for step A.
c) The compounds of the formula I, wherein n is 1 can be prepared by oxidizing compounds of formula I wherein n = 0 (I') with organic oxidizing agents, such as alkyl hydroperoxides, for example cumyl hydroperoxide, and inorganic oxidizing agents, such as peroxides, for example hydrogen peroxide, or transition metal oxides, for example chromium trioxide, and transition metal oxide salts, for example potassium permanganate, potassium or sodium dichromate, are suitable oxidizing agents.
The reaction of the compounds of formula I' with the oxidizing agents takes place in an inert diluent, such as water or a ketone, for example acetone, or in mixtures thereof, in the absence or presence of an acid or in the absence or presence of a base, at temperatures of from -80 to +150°C. - 9 -
The compounds of formula VI can be prepared by the following process d)
0
0
C — A- -B ♦ A step D
+ NH3 + R10COOH NH A R10
R2 R3 RQ --.
Figure imgf000011_0001
VII VIII IX > V- NH-A-B
Figure imgf000011_0002
0 X
R2 O step E
NH„- H R NH-A-B VI
Step D: An isocyanide of formula VII, where A and B are as defined before (see D.Seebach, G.Adam, T.Gees, M.Schiess, W.Weigang, Chem.Ber., 1988, 121 ,507) is reacted with a known compound of formula VIII (R2 and R3 are as defined before), a known compound of formula IX (Rι0 is lower alkyl or H) and ammonia in a solvent (typically an alcohol as methanol or ethanol, tetrahydrofuran, methylenchloride) at a temperature between -20° and +150°C, optionally in the presence of a Lewis acid, typically ZnCI2 (Ugi reaction).
Step E: A compound of formula X, where R2, R3, Rι0, A and B are as defined before, is hydrolysed under acidic or basic conditions at a temperature between 0° and 100°C. Typical acids are mineral acids as HCI, H2S04, organic acids as p-toluenesulfonic acid, methanesulfonic acid, trifluoroacetic acid; typical bases are NaOH, KOH, Ba(OH)2, carbonates, triethylamine, ethyl diisopropylamine; typical solvents are alcohols like ethanol or methanol, tetrahydrofurane, dimethylformamide, dimethylsulfoxide.
Compound VI can be converted to compounds of formula I by step C as described under process b).
The invention relates also to the amino acid derivatives of formula VI, wherein R2, R3, A and B have the meaning as defined for formula I. - 10 -
The sulfonic acid or sulfinic acid or the sulfonic or sulfinic acid derivative of formula III required for process a) or b) and the amino acids of formula IV required for process a) are known per se.
Suitable sulfonic or sulfinic acid derivatives of formula III are any compounds wherein Z is a leaving group, such as sulfonic acid halides or sulfinic acid halides, e.g. sulfochlorides or sulfinic acid chlorides; symmetrical or mixed anhydrides; and activated forms of sulfonic acid or sulfinic acid produced in situ using condensation agents, such as dicyclohexyl- carbodiimide or carbonyldiimidazole.
Surprisingly, it has now been found that compounds of formula I have for practical purposes a very advantageous biocidal spectrum in the control of phytopathogenic microorganisms, especially fungi. They possess very advantageous curative and preventive properties and are used in the protection of numerous crop plants. With the compounds of formula I it is possible to inhibit or destroy pests occurring on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later, for example, also remain protected against phytopathogenic fungi. The novel compounds of formula I prove to be preferentially effective against specific genera of the fungus class Fungi imperfecti (e.g. Cercospora), Basidiomycetes (e.g. Puccinia) and Ascomycetes (e.g. Erysiphe and Venturia) and especially against Oomycetes (e.g. Plasmopara, Peronospora, Bremia, Pythium, Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phytopathogenic fungi. The compounds of formula I can also be used as dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phytopathogenic fungi that occur in the soil.
The invention relates also to compositions comprising compounds of formula I as active ingredients, especially plant-protecting compositions, and to the use thereof in the agricultural sector or related fields.
In addition, the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances herein described. Also included is a method for the treatment of plants which comprises applying the novel compounds of formula I or the novel compositions. - 11 -
Target crops to be protected within the scope of this invention comprise, for example, the following species of plants: cereals (wheat, barley, rye, oats, rice, maize, sorghum, spelt, triticale and related species); beet (sugar beet and fodder beet); pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas and soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans and groundnuts); cucumber plants (marrows, cucumbers and melons); fibre plants (cotton, flax, hemp and jute); citrus fruit (oranges, lemons, grapefruit and mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika); lauraceae (avocados, cinnamon and camphor) and plants such as tobacco, nuts, coffee, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, and also ornamentals.
The compounds of formula I are normally applied in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with further active ingredients. Those further active ingredients may be fertilizers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides, and insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application- promoting adjuvants customarily employed in formulation technology.
Suitable carriers and adjuvants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binding agents or fertilizers. Such carriers are for example described in WO 97/33890.
A preferred method of applying a compound of formula I, or an agrochemical composition comprising at least one of those compounds, is application to the foliage of the plants (foliar application), the frequency and the rate of application depending upon the risk of infestation by the pathogen in question. The compounds of formula I may also be applied to propagation material (grains, fruits, tubers, shoots, cuttings, roots etc.) (dressing), for example either by impregnating cereal grains (seeds) or potato tubers or freshly cut shoots with a liquid formulation of the active ingredient or by coating them with a solid formulation. - 12 -
The compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e.g into emulsifiable concentrates, coatable pastes, directly sprayable or dilutabie solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and also encapsulations in e g. polymer substances. As with the nature of the compositions, the methods of application, such as spraying, atomizing, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
Advantageous rates of application are normally from 1 g to 2kg of active ingredient (a.i.) per hectare, preferably from 10g to 1 kg a.i./ha, especially from 25g to 750g a.i./ha When used as seed dressings, rates of from 0.001 g to 1.0g of active ingredient per kg of seed are advantageously used
The formulations, i.e the compositions, preparations or mixtures comprising the compound (active ingredient) of formula I and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredient with extenders, e.g. solvents, solid carriers and, where appropriate, surface- active compounds (surfactants).
The compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.
Mixing components which are particularly preferred are azoles such as azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutnafol, hexaconazole, imazaltl, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pynfenox, prochloraz, propiconazole, tebuconazole, tetraconazole, tπadimefon, tnadimenol, tπflumizole or tnticonazole; pyπmidinyl carbinoles such as ancymidol.fenarimol or nuanmol; 2-amιno-pyrιmιdιne such as bupinmate, dimethiπmol or ethinmol; morpholines such as dodemorph, fenpropidin, fenpropimorph, spiroxamin or tridemorph; anilinopyπmidines such as cyprodinil, mepanipyπm or pyπmethanil; pyrroles such as fenpiclonil or fludioxonil; phenylamides such as benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace or oxadixyl; benzimidazoles such as benomyl, carbendazim, debacarb, fubendazole or thiabendazole, - 13 -
dicarboximides such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone or vinclozolin; carboxamides such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin or thifluzamide; guanidines such as guazatine, dodine or iminoctadine; strobilurines such as azoxystrobin, kresoxim-methyl, metominostrobin, SSF-129, 2-[(2-trifluoromethyl)-pyrid-6- yloxymethyl]-3-methoxyacrylate or 2-[α{[(α-methyl-3-trifluoromethyl-benzyl)imino]-oxy}-o- tolylj-giyoxylic acid-methylester-O-methyloxime; dithiocarbamates such as ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb or ziram; N-halomethylthio- dicarboximides such as captafol, captan, dichlofluanid, fluoromide, folpet or tolyf luanid; copper compounds such as Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper or oxine-copper; nitrophenol derivatives such as dinocap or nitrothal-isopropyl; organo phosphorous derivatives such as edifenphos, iprobenphos, isoprothioiane, phosdiphen, pyrazophos or tolclofos-methyl; and other compounds of diverse structures such as acibenzolar-S-methyl, anilazine, blasticidin-S, chinomethionat, chloroneb, chlorothalonil, cymoxanil, dichlone, diclomezine, dicloran, diethofencarb.dimethomorph, dithianon, etridiazole, famoxadone, fentin, ferimzone, fluazinam, flusulfamide, fenhexamid, fosetyl-aluminium, hymexazol, kasugamycin, methasulfocarb.pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, sulfur, triazoxide, tricyclazole, triforine or validamycin.
The agrochemical compositions usually comprise 0.1 to 99% by weight, preferably 0.1 to 95% by weight, of a compound of formula I, 99.9 to 1 % by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and 0 to 25% by weight, preferably 0.1 to 25% by weight, of a surfactant.
Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.
The Examples which follow illustrate the invention described above, without limiting the scope thereof in any way. Temperatures are given in degrees Celsius.
Table 1 : Compounds of formula 1.1 - 14 -
O R II
R, S NH
II < (1.1)
(0)n R3 NH-A— B
wherein Ri is methyl and n is the number one and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 2 : Compounds of formula 1.1 wherein Ri is ethyl and n is the number one and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 3 : Compounds of formula 1.1 wherein Ri is ethyl and n is zero and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 4 : Compounds of formula 1.1 wherein Ri is propyl and n is the number one and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 5 : Compounds of formula 1.1 wherein Ri is propyl and n is zero and where the combination of R , R3, A and B corresponds to one line in Table A.
Table 6 : Compounds of formula 1.1 wherein R, is isopropyl and n is the number one and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 7 : Compounds of formula 1.1 wherein Ri is isopropyl and n is zero and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 8 : Compounds of formula 1.1 wherein Ri is butyl and n is the number one and where the combination of R2) R3, A and B corresponds to one line in Table A. - 15 -
Table 9 : Compounds of formula 1.1 wherein Ri is butyl and n is zero and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 10 : Compounds of formula 1.1 wherein Ri is 3-chloro-propyl and n is the number one and where the combination of R , R3,
A and B corresponds to one line in Table A.
Table 11 : Compounds of formula 1.1 wherein Ri is dimethylamino and n is the number one and where the combination of R , R3,
A and B corresponds to one line in Table A.
Table 12 : Compounds of formula 1.1 wherein Ri is phenyl and n is the number one and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 13 : Compounds of formula 1.1 wherein Ri is benzyl and n is the number one and where the combination of R2, R3, A and B corresponds to one line in Table A.
Table 14 : Compounds of formula I.2
(I.2)
Figure imgf000017_0001
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 15 : Compounds of formula I.3 O . O OCH,
R, S NH
(0)n R3 NH— CH— CH2 ( XV-OEthyl (L3) - 16
wherein R is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 16 : Compounds of formula I.4
O R2 n R — s " — H — I — /,
1 n I \ (I.4)
(o)n R, NH — CH.; ■CH
Figure imgf000018_0001
wherein R is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 17 : Compounds of formula 1.5
O R.
II '2 O OCH„ R, S NH- .5)
(o)n R i NH — CH2 — CH, \\ (I
Figure imgf000018_0002
\ = wherein R2 is hydrogen and where the combination of R1 p R3 and n corresponds to one line in Table B.
Table 18 : Compounds of formula 1.6
O R,
II OCH,
R; -s— NH- CH,
II (I.6)
(o)n R NH — CH CH2- Ck wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 19 : Compounds of formula I.7 O R ',2 Q
Rr •NH-
(0)n R3 f NH— CH — (IJ)
Figure imgf000018_0003
17
wherein R is hydrogen and where the combination of R1 t R3 and n corresponds to one line in Table B.
Table 20 : Compounds of formula I.8
O R
II * o
R -s- •NH-
II Λ
(o)n R NH — CH2 — CH
Figure imgf000019_0001
wherein R is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 21 : Compounds of formula I.9
R ■S- ■ NH-
I I '2 ^° (I.9)
(o) n R, NH — CH ;
Figure imgf000019_0002
^
CH,
wherein R2 is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 22 : Compounds of formula 1.10
O
II
-s— NH
II (1.10) (0)n
Figure imgf000019_0003
wherein R2 is hydrogen and where the combination of R^ R3 and n corresponds to one line in Table B.
Table 23 : Compounds of formula 1.1 1 O R 2, 0 OCH,
-S NH-
II 1 ) (0)n R NH — CH2— CH, <y . (1.1
-CH, - 18
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 24 : Compounds of formula 1.12
O R,
II O
R •S — NH-
II f (1.12) (0)n R, NH — CH, — CH
Figure imgf000020_0001
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 25 : Compounds of formula 1.13 O R, O
R; S- -NH-
II < (1.13)
(0)n R, NH — CH2-
Figure imgf000020_0002
wherein R2 is hydrogen and where the combination of R., R3 and n corresponds to one line in Table B.
Table 26 : Compounds of formula 1.14 O R, O
-NH- Λ (1.14)
(0)n R NH — CH2 — CH
Figure imgf000020_0003
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 27 : Compounds of formula 1.15 O R OCH,
Rr -NH- ^ CH, (1.15)
II (0)n R3 NH — CH CH2- _5-°v Cl
Figure imgf000020_0004
19 -
wherein R2 is hydrogen and where the combination of R,, R3 and n corresponds to one line in Table B.
Table 28 : Compounds of formula 1.16
II '2 O
R,- ■s- -NH- \ (1.16)
R, NH — CH2—
(0)n
Figure imgf000021_0001
o y CH,
wherein R2 is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 29 : Compounds of formula 1.17
OCH3
-S NH- ^ CH,
II Λ (1.17)
(o)n R, NH — CH- -CH, o wherein R2 is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 30 : Compounds of formula 1.18 O R,
R, S NH- Y OCH,
(1.18)
(0)n NH — CH -CH2- £$- wherein R2 is hydrogen and where the combination of R1 ( R3 and n corresponds to one line in Table B.
Table 31 : Compounds of formula 1.19 O R | 2, O OCH,
R, S NH- CH, (1.19)
(0)n R3 NH — CH — CH2 j-°H 20
wherein R2 is hydrogen and where the combination of R1 t R3 and n corresponds to one line in Table B.
Table 32 : Compounds of formula 1.20 O R„ O
Rr -S- •NH-
II Λ (I.20)
(0)n NH — CH; -CH
Figure imgf000022_0001
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 33 : Compounds of formula 1.21 O R, .o OCH3 R — s — NH. CH, (1.21) 1 II (0)n R, NH — CH- -CH; 0 °A wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 34 : Compounds of formula I.22 O R,
Rr -NH- Λ S (1.22)
(0)n R3 NH — CH2— CH
Figure imgf000022_0002
Cl
Figure imgf000022_0003
wherein R2 is hydrogen and where the combination of R1 ( R3 and n corresponds to one line in Table B.
Table 35 : Compounds of formula I.23 21
O
II
R -S NH- * (I.23)
II Λ (0)n R, NH- -CH
Figure imgf000023_0001
wherein R2 is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 36 : Compounds of formula I.24
R '2, O
-S— ■NH- II (I.24)
(0)n i NH — CH, — CH
Figure imgf000023_0002
wherein R2 is hydrogen and where the combination of R1 ( R3 and n corresponds to one line in Table B.
Table 37 : Compounds of formula I.25 O R,
R, S NH- CH,
Λ (I.25)
(0)n NH — CH- -CH
Figure imgf000023_0003
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 38 : Compounds of formula I.26 O R,
II .0 R. S NH- Λ
(0)n R3 NH — CH— CH
Figure imgf000023_0004
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B. 22 -
Table 39 : Compounds of formula 1.27 O R,
R, S NH- Λ (1.27)
(0)n R, NH — CH,- ■CH
Figure imgf000024_0001
wherein R2 is hydrogen and where the combination of R1 t R3 and n corresponds to one line in Table B.
Table 40 : Compounds of formula I.28 O R, O OCH,
-S- -NH-
II < (I.28)
(0)n NH — CH, —
Figure imgf000024_0002
Figure imgf000024_0003
wherein R2 is hydrogen and where the combination of R1 f R3 and n corresponds to one line in Table B.
Table 41 : Compounds of formula I.29
O
II ' v o.
-S NH-
II (I.29) (0)n y NH — CH,- -CH
Figure imgf000024_0004
wherein R2 is hydrogen and where the combination of R^ R3 and n corresponds to one line in Table B.
Table 42 : Compounds of formula 1.30 O R ',2 O OCH,
R; -s— NH- (I.30)
II
(o)n R i NH — CH — O
Figure imgf000024_0005
OCF,
Figure imgf000024_0006
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B. - 23
Table 43 : Compounds of formula 1.31
R, S NH- Λ *
(1.31 )
(0)n R NH — CH2 —
Figure imgf000025_0001
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 44 : Compounds of formula I.32 O R, O
R, S NH- (I.32)
(0)n NH — CH, — CH
Figure imgf000025_0002
wherein R2 is hydrogen and where the combination of R1 ( R3 and n corresponds to one line in Table B.
Table 45 : Compounds of formula I.33
O R.
II O
-S NH-
II (0)n NH — CH -CH (I.33)
Figure imgf000025_0003
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B.
Table 46 : Compounds of formula I.34 O R, OCH,
R -S — NH- '/ II
R 2
(0)n , N°H — CH ,— en,— Vo V Cl (I.34)
Figure imgf000025_0004
wherein R2 is hydrogen and where the combination of Ri, R3 and n corresponds to one line in Table B. - 24 -
Table 47 : Compounds of formula 1.35
O
II OCH,
-s— NH- /f
II Λ (1.35) (0)n R NH — CH2 -CH <y° yy -Cl
wherein R is hydrogen and where the combination of R1 ( R3 and n corresponds to one line in Table B.
Table 48 : Compounds of formula 1.36 O
R, S NH
(I.36)
(0)n
Figure imgf000026_0001
wherein R2 is hydrogen and where the combination of R<,, R3 and n corresponds to one line in Table B.
Table 49 : Compounds of formula I.37 O R,
R -NH-
(I.37)
(0)n NH — CH; CH
Figure imgf000026_0002
wherein R is hydrogen and where the combination of R*,, R3 and n corresponds to one line in Table B.
Table 50 : Compounds of formula I.38
II o
R -S- -NH- yy
II (1.38) (0)n NH — CH; -CH O CH,
Figure imgf000026_0003
C:H,
wherein R2 is hydrogen and where the combination of R1 t R3 and n corresponds to one line in Table B. 25
Table A (wherein Et means ethyl and c. means cyclo)
No. R2 R3 A B
A.1 H phenyl -CH2- phenyl
A.2 H phenyl -CH2- 4-CI-phenyl
A.3 H phenyl -CH2- 3,4-di-CI-phenyl
A.4 H phenyl -CH2- 2,4-di-CI-phenyl
A.5 H phenyl -CH2- 4-Br-phenyl
A.6 H phenyl -CH2- 4-CH3-phenyl
A.7 H phenyl -CH2- 4-Et-phenyl
A.8 H phenyl -CH2- 4-OCH3-phenyl
A.9 H phenyl -CH2- 4-CF3-phenyl
A.10 H phenyl -CH2- 4-c.C5H9-phenyl
A.11 H phenyl -CH2- 3-OCH3-4-phenoxy-phenyl
A.12 H phenyl -CH2- 3-OCH3-4-SCH3-phenyl
A.13 H phenyl -CH2- 4-CH3OOC-phenyl
A.14 H phenyl -CH2- 3-N0 -phenyl
A.15 H phenyl -CH2- 4-CN-phenyl
A.16 H phenyl -CH2- 4-N(CH3)2-phenyl
A.17 H phenyl -CH(CH3)- phenyl
A.18 H phenyl -CH(CH3)- 4-CI-phenyl
A.19 H phenyl -CH(CH3)- 3,4-di-CI-phenyl
A.20 H phenyl -CH(CH3)- 2,4-di-CI-phenyl
A.21 H phenyl -CH(CH3)- 4-Br-phenyl
A.22 H phenyl -CH(CH3)- 4-CH3-phenyl
A.23 H phenyl -CH(CH3)- 4-Et-phenyl
A.24 H phenyl -CH(CH3)- 4-OCH3-phenyl
A.25 H phenyl -CH(CH3)- 4-CF3-phenyl
A.26 H phenyl -CH(CH3)- 4-c.C5H9-phenyl
A.27 H phenyl -CH(CH3)- 3-OCH3-4-phenoxy-phenyl
A.28 H phenyl -CH(CH3)- 3-OCH3-4-SCH3-phenyl
A.29 H phenyl -CH(CH3)- 4-CH3OOC-phenyl
Figure imgf000027_0001
A.30 H phenyl -CH(CH3)- 3-N02-phenyl - 26
A.31 H phenyl -CH(CH3)- 4-CN-phenyl
A.32 H phenyl -CH(CH3)- 4-N(CH3)2-phenyl
A.33 H phenyl -CH2CH2- phenyl
A.34 H phenyl -CH2Cπ2" 4-CI-phenyl
A.35 H phenyl -CH2CH2- 3,4-di-CI-phenyl
A.36 H phenyl -CH2CH2- 2,4-di-CI-phenyl
A.37 H phenyl -CH2CH2- 4-Br-phenyl
A.38 H phenyl -CH2CH2- 4-CH3-phenyl
A.39 H phenyl -GH2CH2- 4-Et-phenyl
A.40 H phenyl -CH2GH2- 4-OCH3-phenyl
A.41 H phenyl -CH2CH2- 4-CF3-phenyl
A.42 H phenyl -CH2CH2- 4-c.C5H9-phenyl
A.43 H phenyl -GH2CH2- 3-OCH3-4-phenoxy-phenyl
A.44 H phenyl -CH2CH2- 3-OCH3-4-SCH3-phenyl
A.45 H phenyl -CH2Cπ2- 4-CH3OOC-phenyl
A.46 H phenyl -CH2CH2- 3-N02-phenyl
A.47 H phenyl -Cπ2CH2- 4-CN-phenyl
A.48 H phenyl -CH2CH2- 4-N(CH3)2-phenyl
A.49 H phenyl -CH(CH3)CH2- phenyl
A.50 H phenyl -CH(CH3)CH2- 4-CI-phenyl
A.51 H phenyl -CH(CH3)CH2- 3,4-di-CI-phenyl
A.52 H phenyl -CH(CH3)CH2- 2,4-di-CI-phenyl
A.53 H phenyl -CH(CH3)CH2- 4-Br-phenyl
A.54 H phenyl -CH(CH3)CH2- 4-CH3-phenyl
A.55 H phenyl -CH(CH3)CH2- 4-Et-phenyl
A.56 H phenyl -CH(CH3)CH2- 4-OCH3-phenyl
A.57 H phenyl -CH(CH3)CH2- 4-CF3-phenyl
A.58 H phenyl -CH(CH3)CH2- 4-c.C5H9-phenyl
A.59 H phenyl -CH(CH3)CH2- 3-OCH3-4-phenoxy-phenyl
A.60 H phenyl -CH(CH3)CH2- 3-OCH3-4-SCH3-phenyl
A.61 H phenyl -CH(CH3)CH2- 4-CH3OOC-phenyl
A.62 H phenyl -CH(CH3)CH2- 3-N02-phenyl
Figure imgf000028_0001
A.63 H phenyl -CH(CH3)CH2- 4-CN-phenyl - 27 -
A.64 H phenyl -CH(CH3)CH2- 4-N(CH3)2-phenyl
A.65 H 4-CI-phenyl -CH2- phenyl
A.66 H 4-CI-phenyl -CH2- 4-CI-phenyl
A.67 H 4-CI-phenyl -CH2- 3,4-di-CI-phenyl
A.68 H 4-CI-phenyl -CH2- 2,4-di-CI-phenyl
A.69 H 4-CI-phenyl -CH2- 4-Br-phenyl
AJO H 4-CI-phenyl -CH2- 4-CH3-phenyl
AJ1 H 4-CI-phenyl -CH2- 4-Et-phenyl
AJ2 H 4-CI-phenyl -CH2- 4-OCH3-phenyl
AJ3 H 4-CI-phenyl -CH2- 4-CF3-phenyl
A.74 H 4-CI-phenyl -CH2- 4-c.C5H9-phenyl
AJ5 H 4-CI-phenyl -CH2- 3-OCH3-4-phenoxy-phenyl
AJ6 H 4-CI-phenyl -CH2- 3-OCH3-4-SCH3-phenyl
AJ7 H 4-CI-phenyl -CH2- 4-CH3OOC-phenyl
AJ8 H 4-CI-phenyl -CH2- 3-N02-phenyl
AJ9 H 4-CI-phenyl -CH2- 4-CN-phenyl
A.80 H 4-CI-phenyl -CH2- 4-N(CH3)2-phenyl
A.81 H 4-CI-phenyl -CH(CH3)- phenyl
A.82 H 4-CI-phenyl -CH(CH3)- 4-CI-phenyl
A.83 H 4-CI-phenyl -CH(CH3)- 3,4-di-CI-phenyl
A.84 H 4-CI-phenyl -CH(CH3)- 2,4-di-CI-phenyl
A.85 H 4-CI-phenyl -CH(CH3)- 4-Br-phenyl
A.86 H 4-CI-phenyl -CH(CH3)- 4-CH3-phenyl
A.87 H 4-CI-phenyl -CH(CH3)- 4-Et-phenyl
A.88 H 4-CI-phenyl -CH(CH3)- 4-OCH3-phenyl
A.89 H 4-CI-phenyl -CH(CH3)- 4-CF3-phenyl
A.90 H 4-CI-phenyl -CH(CH3)- 4-c.C5H9-phenyl
A.91 H 4-CI-phenyl -CH(CH3)- 3-OCH3-4-phenoxy-phenyl
A.92 H 4-CI-phenyl -CH(CH3)- 3-OCH3-4-SCH3-phenyl
A.93 H 4-CI-phenyl -CH(CH3)- 4-CH3OOC-phenyl
A.94 H 4-CI-phenyl -CH(CH3)- 3-N0 -phenyl
A.95 H 4-CI-phenyl -CH(CH3)- 4-CN-phenyl
Figure imgf000029_0001
A.96 H 4-CI-phenyl
Figure imgf000029_0002
-CH(CH3)- 4-N(CH3)2-phenyl - 28
A.97 H 4-CI-phenyl -CH2CH2- phenyl
A.98 H 4-CI-phenyl -CH CH2- 4-CI-phenyl
A.99 H 4-CI-phenyl -CH2CH2- 3,4-di-CI-phenyl
A.100 H 4-CI-phenyl -CH2CH2- 2,4-di-CI-phenyl
A.101 H 4-CI-phenyl -CH2CH2- 4-Br-phenyl
A.102 H 4-CI-phenyl -CH2Cπ2- 4-CH3-phenyl
A.103 H 4-CI-phenyl -Cπ2CH2- 4-Et-phenyl
A.104 H 4-CI-phenyl -CH2CH2- 4-OCH3-phenyl
A.105 H 4-CI-phenyl -CH2CH2- 4-CF3-phenyl
A.106 H 4-CI-phenyl -CH2CH2- 4-c.C5H9-phenyl
A.107 H 4-CI-phenyl -CH2CH2- 3-OCH3-4-phenoxy-phenyl
A.108 H 4-CI-phenyl -CH2CH2- 3-OCH3-4-SCH3-phenyl
A.109 H 4-CI-phenyl -CH2CH2- 4-CH3OOC-phenyl
A.110 H 4-CI-phenyl -CH2CH2- 3-N02-phenyl
A.1 1 1 H 4-CI-phenyl -CH2CH2- 4-CN-phenyl
A.1 12 H 4-CI-phenyl -CH2CH2- 4-N(CH3)2-phenyl
A.113 H 4-CI-phenyl -CH(CH3)CH2- phenyl
A.114 H 4-CI-phenyl -CH(CH3)CH2- 4-CI-phenyl
A.115 H 4-CI-phenyl -CH(CH3)CH2- 3,4-di-CI-phenyl
A.116 H 4-CI-phenyl -CH(CH3)CH2- 2,4-di-CI-phenyl
A.117 H 4-CI-phenyl -CH(CH3)CH2- 4-Br-phenyl
A.118 H 4-CI-phenyl -CH(CH3)CH2- 4-CH3-phenyl
A.119 H 4-CI-phenyl -CH(CH3)CH2- 4-Et-phenyl
A.120 H 4-CI-phenyl -CH(CH3)CH2- 4-OCH3-phenyl
A.121 H 4-CI-phenyl -CH(CH3)CH2- 4-CF3-phenyl
A.122 H 4-CI-phenyl -CH(CH3)CH2- 4-c.C5H9-phenyl
A.123 H 4-CI-phenyl -CH(CH3)CH2- 3-OCH3-4-phenoxy-phenyl
A.124 H 4-CI-phenyl -CH(CH3)CH2- 3-OCH3-4-SCH3-phenyl
A.125 H 4-CI-phenyl -CH(CH3)CH2- 4-CH3OOC-phenyl
A.126 H 4-CI-phenyl -CH(CH3)CH2- 3-N02-phenyl
A.127 H 4-CI-phenyl -CH(CH3)CH2- 4-CN-phenyl
A.128 H 4-CI-phenyl -CH(CH3)CH2- 4-N(CH3)2-phenyl
Figure imgf000030_0001
A.129 H 3,4-di-CI-phenyl -CH2- phenyl - 29 -
A.130 H 3,4-di-CI-phenyl -CH2- 4-CI-phenyl
A.131 H 3,4-di-CI-phenyl -CH2- 3,4-di-CI-phenyl
A.132 H 3,4-di-CI-phenyl -CH2- 2,4-di-CI-phenyl
A.133 H 3,4-di-CI-phenyl -CH2- 4-Br-phenyl
A.134 H 3,4-di-CI-phenyl -CH2- 4-CH3-phenyl
A.135 H 3,4-di-CI-phenyl -CH2- 4-Et-phenyl
A.136 H 3,4-di-CI-phenyl -CH2- 4-OCH3-phenyl
A.137 H 3,4-di-CI-phenyl -CH2- 4-CF3-phenyl
A.138 H 3,4-di-CI-phenyl -CH2- 4-c.C5H9-phenyl
A.139 H 3,4-di-CI-phenyl -CH2- 3-OCH3-4-phenoxy-phenyl
A.140 H 3,4-di-CI-phenyl -CH2- 3-OCH3-4-SCH3-phenyl
A.141 H 3,4-di-CI-phenyl -CH2- 4-CH3OOC-phenyl
A.142 H 3,4-di-CI-phenyl -CH2- 3-N02-phenyl
A.143 H 3,4-di-CI-phenyl -CH2- 4-CN-phenyl
A.144 H 3,4-di-CI-phenyl -CH2- 4-N(CH3)2-phenyl
A.145 H 3,4-di-CI-phenyl -CH(CH3)- phenyl
A.146 H 3,4-di-CI-phenyl -CH(CH3)- 4-CI-phenyl
A.147 H 3,4-di-CI-phenyl -CH(CH3)- 3,4-di-CI-phenyl
A.148 H 3,4-di-CI-phenyl -CH(CH3)- 2,4-di-CI-phenyl
A.149 H 3,4-di-CI-phenyl -CH(CH3)- 4-Br-phenyl
A.150 H 3,4-di-CI-phenyl -CH(CH3)- 4-CH3-phenyl
A.151 H 3,4-di-CI-phenyl -CH(CH3)- 4-Et-phenyl
A.152 H 3,4-di-CI-phenyl -CH(CH3)- 4-OCH3-phenyl
A.153 H 3,4-di-CI-phenyl -CH(CH3)- 4-CF3-phenyl
A.154 H 3,4-di-CI-phenyl -CH(CH3)- 4-c.C5H9-phenyl
A.155 H 3,4-di-CI-phenyl -CH(CH3)- 3-OCH3-4-phenoxy-phenyl
A.156 H 3,4-di-CI-phenyl -CH(CH3)- 3-OCH3-4-SCH3-phenyl
A.157 H 3,4-di-CI-phenyl -CH(CH3)- 4-CH3OOC-phenyl
A.158 H 3,4-di-CI-phenyl -CH(CH3)- 3-N02-phenyl
A.159 H 3,4-di-CI-phenyl -CH(CH3)- 4-CN-phenyl
A.160 H 3,4-di-CI-phenyl -CH(CHa)- 4-N(CH3)2-phenyl
A.161 H 3,4-di-CI-phenyl -CH2CH2- phenyl
Figure imgf000031_0001
A.162 H 3,4-di-CI-phenyl -CH2CH2- 4-CI-phenyl - 30
A.163 H 3,4-di-CI-phenyl -CH2CH2- 3,4-di-CI-phenyl
A.164 H 3,4-di-CI-phenyl -CH2CH2- 2,4-di-CI-phenyl
A.165 H 3,4-di-CI-phenyl -CH2CH2- 4-Br-phenyl
A.166 H 3,4-di-CI-phenyl -CH2CH2- 4-CH3-phenyl
A.167 H 3,4-di-CI-phenyl -CH2CH2- 4-Et-phenyl
A.168 H 3,4-di-CI-phenyl -CH CH2- 4-OCH3-phenyl
A.169 H 3,4-di-CI-phenyl -CH2CH2- 4-CF3-phenyl
A.170 H 3,4-di-CI-phenyl -CH2CH2- 4-c.C5H9-phenyl
A.171 H 3,4-di-CI-phenyl -CH2CH2- 3-OCH3-4-phenoxy-phenyl
A.172 H 3,4-di-CI-phenyl -GH2GH2- 3-OCH3-4-SCH3-phenyl
A.173 H 3,4-di-CI-phenyl -CH2CH2- 4-CH3OOC-phenyl
A.174 H 3,4-di-CI-phenyl -CH2CH2- 3-N02-phenyl
A.175 H 3,4-di-CI-phenyl -CH2CH2- 4-CN-phenyl
A.176 H 3,4-di-CI-phenyl -CH2CH2- 4-N(CH3)2-phenyl
A.177 H 3,4-di-CI-phenyl -CH(CH3)CH2- phenyl
A.178 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-CI-phenyl
A.179 H 3,4-di-CI-phenyl -CH(CH3)CH2- 3,4-di-CI-phenyl
A.180 H 3,4-di-CI-phenyl -CH(CH3)CH2- 2,4-di-CI-phenyl
A.181 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-Br-phenyl
A.182 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-CH3-phenyl
A.183 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-Et-phenyl
A.184 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-OCH3-phenyl
A.185 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-CF3-phenyl
A.186 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-c.C5H9-phenyl
A.187 H 3,4-di-CI-phenyl -CH(CH3)CH2- 3-OCH3-4-phenoxy-phenyl
A.188 H 3,4-di-CI-phenyl -CH(CH3)CH2- 3-OCH3-4-SCH3-phenyl
A.189 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-CH3OOC-phenyl
A.190 H 3,4-di-CI-phenyl -CH(CH3)CH2- 3-N02-phenyl
A.191 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-CN-phenyl
A.192 H 3,4-di-CI-phenyl -CH(CH3)CH2- 4-N(CH3)2-phenyl
A.193 H 4-Br-phenyl -CH2CH2- phenyl
A.194 H 4-Br-phenyl -CH2CH2- 4-CI-phenyl
Figure imgf000032_0001
A.195 H 4-Br-phenyl -CH2CH2- 4-CH3-phenyl - 31 -
A.196 H 4-Br-phenyl -CH2GH2- 4-Et-phenyl
A.197 H 4-Br-phenyl -CH2CH2- 4-OCH3-phenyl
A.198 H 4-Br-phenyl -CH2CH2- 3-OCH3-4-phenoxy-phenyl
A.199 H 4-Br-phenyl -Cπ2CH2- 3-OCH3-4-SCH3-phenyl
A.200 H 4-Br-phenyl -CH(CH3)- phenyl
A.201 H 4-Br-phenyl -CH(CH3)- 4-CI-phenyl
A.202 H 4-Br-phenyl -CH(CH3)- 4-CH3-phenyl
A.203 H 4-Br-phenyl -CH(CH3)- 4-Et-phenyl
A.204 H 4-Br-phenyl -CH(CH3)- 4-OCH3-phenyl
A.205 H 4-Br-phenyl -CH(CH3)- 3-OCH3-4-phenoxy-phenyl
A.206 H 4-Br-phenyl -CH(CH3)- 3-OCH3-4-SCH3-phenyl
A.207 H 4-CF3-phenyl -CH2CH2- phenyl
A.208 H 4-CF3-phenyl -CH2CH2- 4-CI-phenyl
A.209 H 4-CF3-phenyl -CH2Cπ2- 4-CH3-phenyl
A.210 H 4-CF3-phenyl -CH2CH2- 4-Et-phenyl
A.211 H 4-CF3-phenyl -CH2CH2- 4-OCH3-phenyl
A.212 H 4-CF3-phenyl -CH2GH2- 3-OCH3-4-phenoxy-phenyl
A.213 H 4-CF3-phenyl -CH2CH2- 3-OCH3-4-SCH3-phenyl
A.214 H 4-CF3-phenyl -CH(CH3)- phenyl
A.215 H 4-CF3-phenyl -CH(CH3)- 4-CI-phenyl
A.216 H 4-CF3-phenyl -CH(CH3)- 4-CH3-phenyl
A.217 H 4-CF3-phenyl -CH(CH3)- 4-Et-phenyl
A.218 H 4-CF3-phenyl -CH(CH3)- 4-OCH3-phenyl
A.219 H 4-CF3-phenyl -CH(CH3)- 3-OCH3-4-phenoxy-phenyl
A.220 H 4-CF3-phenyl -CH(CH3)- 3-OCH3-4-SCH3-phenyl
A.221 H 4-CH3-phenyl -CH2CH2- phenyl
A.222 H 4-CH3-phenyl -Cπ2CH2- 4-CI-phenyl
A.223 H 4-CH3-phenyl -CH2CH2- 4-CH3-phenyl
A.224 H 4-CH3-phenyl -CH2CH2- 4-Et-phenyl
A.225 H 4-CH3-phenyl -CH2CH2- 4-OCH3-phenyl
A.226 H 4-CH3-phenyl -CH2CH2- 3-OCH3-4-phenoxy-phenyl
A.227 H 4-CH3-phenyl -CH2CH2- 3-OCH3-4-SCH3-phenyl
Figure imgf000033_0001
A.228 H 4-CH3-phenyl -CH(CH3)- phenyl >- c O φ sz
Os c OS ex φ
>- sz
63 X CL
H c — , , υ . φ X >- >- >- >- >•. > . >- c c φ r O >. c >- c ^ c >> c c
CL φ φ Φ φ >- c c c φ φ φ Φ φ
>. c φ >- SZ O >- c φ sz c φ sz >> c φ sz c e Φ sz >s c
CL φ sz >> c φ sz c L c φ sz >- c
■<fr c x φ sz c φ sz c sz c ex c φ z ex c sz C sz x c sz c sz CL c sz CL c sz e c sz CL sz CL Φ φ s φ sz L sz CL φ φ
X sz -C CL φ CL φ sz CL ex φ : CL sz CL φ φ sz ex sz CL a. X z sz ex X o CL X Q. X X C CL
X o o X o X o CL X ex
X o X o L X x X CL L
X o X o X
X o ex X
X o C X
X o
O o UJ o o o o o o o o o o o o O o o o o o o o o o o o o o o O o υ
Figure imgf000034_0001
•>*- **• •< co co ■<fr « •* •"■t f f ■"• ■< •<* •<*• <* "-t •«* "* f ■0- ■< ^- i-
X X X X X X X X X X X X X X X X X X X X X X X x x x x
CM o o o o o o o o o o o o o o o o o o o o o o o o xo ox xo xo o ox ox
9 - CO X X X o x." 9 x X X X X X X X X X x x x x x x x x x x x x X X X X X X o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
>- >- >< > >> >>
C C C
CZ CZ CZ cz cz cz c.- c c c c c c Φ
Φ φ φ φ φ
C Φ Φ Φ φ Φ Φ
SZ sz sz sz sz sz - s c >s sz SZ SZ SZ sz sz φ φ Φ c Φ Φ Φ C >- > cz CL ex ex ex CL CL >. >- sz sz >. > >. c >. >> c c c CL CL CL CL CL C C c c C ex ex c c c C- Φ φ Φ Φ φ φ Φ Φ Φ s Φz φ φ φ Φ z sz sz LL LL s Φz SZ sz SZ sz sz O O O O O O sz x: SZ
X X X X X X CL
Figure imgf000034_0002
CL ex CL o o o o o υ CL CL CL CL CL CL
Figure imgf000034_0003
ex Q. CL
TJ TJ u -σ o o O O o o LL LL LL LL o o o o o o o O O O O O CΩ ω ω 4 CO CO co" co" CO* co" 4
- ^*o X X X x x x x X X X X X X X X
X X X X X X X X X X X X X X X X X X o o o o o o o O O O o o o o o o\ as
O en o CM CO in (D N CO en o CM CO in CO s ffl CO CM co m o oo en o CM co CO CO CO CO co CO CO CO co TΓ o in in in in m m m m m in co CO
CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM < < < < < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
OS OS
C >.- c
63 Φ H υ >-. >- >- >-
>> c φ >- c > c φ >> c c c
>- c sz c Φ z > c SZ >< c φ c φ Φ c Φ ex c Φ s e φ x c φ sz >.- c e Φ CL c Φ sz x X
CL Φ φ sz ex Φ φ
X z X sz X sz X sz X X o
X o CL
X o n CL
-L o X o CL
I X o o T IJ
O o O O o o
Figure imgf000035_0001
O o o O O o o o o o l- co co"
>- >.- >. >* >. >- >> >> >> c c C c c c c C C c c c φ Φ Φ φ Φ φ Φ Φ Φ Φ φ Φ sz sz Z sz sz sz sz SZ SZ sz sz sz. a. CL CL ex ex ex ex CL ex CL ex CL
Figure imgf000035_0002
X X X X X X X X X X X X X X X o o o o o o o o o o o o
O O O O o o o o o o cc I I I I I I I I I I I I o o o o o o ^ ^■ f ' - 'M- 'M- tf 't ^ t l- ^ ^
CO CO X X X X X X x IE X X X X X X X X X
O O o o o o o o o o o o o o o o o c ι- O T- O T-
>> >. >> c c c c C c φ φ φ φ Φ φ sz sz SZ sz c c c c c c φ φ φ CL CL CL CL Φ Φ Φ sz sz sz sz sz sz co ex ex CL ex ex a.
5^ >> sz c c c X X X X X X φ φ φ o O O o o o X X X X X X c c φ o O O o o o O O o o o φ φ sz sz CO ex ex c
TJ TJ TJ TJ TJ T IJ T O
CO CO CD 4 4 4 IJ TJ TJ
"■ 4 o o φ
CO co" o" CO CO co" co" co" co" co" co" co" F c
TJ uu >. >. c CL CL ex ex "δ o O o o . φ 3 1 .1
X X CL ex ex ex I J ex
SO X X o ^ >> ro O O O X x x x x x x x x x x x x φ r DC o m LU CM CM z -
0\ 5 OS o m
CM CO in O 00 en o CM CO Tj- m O CO Φ CD CO CD CD CD CD CD CO f- o CJ CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM Si o CM CO •>fr m CO r^- 00 cn
< < < < < < < < < < < < < < < < <
Figure imgf000035_0003
H Z ύ cα ύ ω CQ m CQ m ω n m CQ
34 -
B.13 3-CI-propyl 1 4-CI-phenyl
B.14 2-Me-2-propyl 0 4-CI-phenyl
B.15 2-Me-propyl 4-CI-phenyl
B.16 CF3 4-CI-phenyl
B.17 CH2-CF3 4-CI-phenyl
B.18 vinyl 4-CI-phenyl
B.19 cyclopentyl 4-CI-phenyl
B.20 cyclohexyl 4-CI-phenyl
B.21 cyclopentyl 4-CI-phenyl
B.22 cyclohexyl 4-CI-phenyl
B.23 CH2-SO2-CH3 4-CI-phenyl
B.24 phenyl 4-CI-phenyl
B.25 benzyl 4-CI-phenyl
B.26 4-Me-phenyl 4-CI-phenyl
B.27 4-MeS-phenyl 4-CI-phenyl
B.28 4-CF3-phenyl 4-CI-phenyl
B.29 4-CF30-phenyl 4-CI-phenyl
B.30 4-MeO-phenyl 4-CI-phenyl
B.31 3-CH3OOC-phenyl 4-CI-phenyl
B.32 3-CH3CO-phenyl 4-CI-phenyl
B.33 4-CI-phenyl 4-CI-phenyl
B.34 3-N02-phenyl 4-CI-phenyl
B.35 3-CN-phenyl 4-CI-phenyl
B.36 CH3 3,4-di-CI-phenyl
B.37 Et 0 3,4-di-CI-phenyl
B.38 Et 3,4-di-CI-phenyl
B.39 1 -propyl 0 3,4-di-CI-phenyl
B.40 1 -propyl 3,4-di-CI-phenyl
B.41 2-propyl 0 3,4-di-CI-phenyl
B.42 2-propyl 3,4-di-CI-phenyl
B.43 1 -butyl 0 3,4-di-CI-phenyl
B.44 1 -butyl 3,4-di-CI-phenyl
Figure imgf000036_0001
B.45 N(CH3)2 0 3,4-di-CI-phenyl - 35 -
B.46 N(CH3)2 3,4-di-CI-phenyl
B.47 1 -pyrrolidin 3,4-di-CI-phenyl
B.48 3-CI-propyl 3,4-di-CI-phenyl
B.49 2-Me-2-propyl 0 3,4-di-CI-phenyl
B.50 2-Me-propyl 3,4-di-CI-phenyl
B.51 CF3 3,4-di-CI-phenyl
B.52 CH2-CF3 3,4-di-CI-phenyl
B.53 vinyl 3,4-di-CI-phenyl
B.54 cyclopentyl 3,4-di-CI-phenyl
B.55 cyclohexyl 3,4-di-CI-phenyl
B.56 cyclopentyl 3,4-di-CI-phenyl
B.57 cyclohexyl 3,4-di-CI-phenyl
B.58 CH2-S02-CH3 3,4-di-CI-phenyl
B.59 phenyl 3,4-di-CI-phenyl
B.60 benzyl 3,4-di-CI-phenyl
B.61 4-Me-phenyl 3,4-di-CI-phenyl
B.62 4-MeS-phenyl 3,4-di-CI-phenyl
B.63 4-CF3-phenyl 3,4-di-CI-phenyl
B.64 4-CF30-phenyl 3,4-di-CI-phenyl
B.65 4-MeO-phenyl 3,4-di-CI-phenyl
B.66 3-CH3OOC-phenyl 3,4-di-CI-phenyl
B.67 3-CH3CO-phenyl 3,4-di-CI-phenyl
B.68 4-CI-phenyl 3,4-di-CI-phenyl
B.69 3-N02-phenyl 3,4-di-CI-phenyl
B.70 3-CN-phenyl 3,4-di-CI-phenyl
B.71 CH3 phenyl
BJ2 Et 0 phenyl
BJ3 Et phenyl
BJ4 2-propyl 0 phenyl
B.75 2-propyl phenyl
BJ6 N(CH3)2 phenyl
BJ7 CH3 4-Br-phenyl
Figure imgf000037_0001
BJ8 Et 0 4-Br-phenyl - 36 -
B.79 Et 1 4-Br-phenyl
B.80 2-propyl 0 4-Br-phenyl
B.81 2-propyl 4-Br-phenyl
B.82 N(CH3)2 4-Br-phenyl
B.83 CH3 4-CH3-phenyl
B.84 Et 4-CH3-phenyl
B.85 Et 4-CH3-phenyl
B.86 2-propyl 4-CH3-phenyl
B.87 2-propyl 4-CH3-phenyl
B.88 N(CH3)2 4-CH3-phenyl
B.89 CH3 4-CH30-phenyl
B.90 Et 0 4-CH30-phenyl
B.91 Et 4-CH30-phenyl
B.92 2-propyl 0 4-CH30-phenyl
B.93 2-propyl 4-CH30-phenyl
B.94 N(CH3)2 4-CH30-phenyl
B.95 CH3 4-CF3-phenyl
B.96 Et 4-CF3-phenyl
B.97 Et 4-CF3-phenyl
B.98 2-propyl 4-CF3-phenyl
B.99 2-propyl 4-CF3-phenyl
B.100 N(CH3)2 4-CF3-phenyl
B.101 CH3 4-F-phenyl
B.102 Et 0 4-F-phenyl
B.103 Et 4-F-phenyl
B.104 2-propyl 0 4-F-phenyl
B.105 2-propyl 4-F-phenyl
B.106 N(CH3)2 4-F-phenyl
B.107 CH3 4-CF30-phenyl
B.108 Et 0 4-CF30-phenyl
B.109 Et 4-CF30-phenyl
B.110 2-propyl 0 4-CF30-phenyl
Figure imgf000038_0001
B.111 2-propyl 4-CF30-phenyl - 37
B.112 N(CH3)2 4-CF30-phenyl
B.1 13 CH3 3,4-di-CH3-phenyl
B.1 14 Et 3,4-di-CH3-phenyl
B.1 15 Et 3,4-di-CH3-phenyl
B.1 16 2-propyl 3,4-di-CH3-phenyl
B.1 17 2-propyl 3,4-di-CH3-phenyl
B.118 N(CH3)2 3,4-di-CH3-phenyl
B.119 CH3 4-vinyl-phenyl
B.120 Et 4-vinyl-phenyl
B.121 Et 4-vinyl-phenyl
B.122 2-propyl 4-vinyl-phenyl
B.123 2-propyl 4-vinyl-phenyl
B.124 N(CH3)2 4-vinyl-phenyl
B.125 CH3 4-ethynyl-phenyl
B.126 Et 4-ethynyl-phenyl
B.127 Et 4-ethynyl-phenyl
B.128 2-propyl 4-ethynyl-phenyl
B.129 2-propyl 4-ethynyl-phenyl
B.130 N(CH3)2 4-ethynyl-phenyl
B.131 CH3 4-cyclopentyl-phenyl
B.132 Et 4-cyclopentyl-phenyl
B.133 Et 4-cyclopentyl-phenyl
B.134 2-propyl 0 4-cyclopentyl-phenyl
B.135 2-propyl 4-cyclopentyl-phenyl
B.136 N(CH3)2 4-cyclopentyl-phenyl
B.137 Et 0 4-allylO-phenyl
B.138 Et 4-allylO-phenyl
B.139 2-propyl 4-allylO-phenyl
B.140 2-propyl 4-allylO-phenyl
B.141 N(CH3)2 4-allylO-phenyl
B.142 Et 0 4-CH3S-phenyl
B.143 Et 1 4-CH3S-phenyl
Figure imgf000039_0001
B.144 2-propyl 0 4-CH3S-phenyl - 38 -
B.145 2-propyl 1 4-CH3S-phenyl
B.146 N(CH3)2 1 4-CH3S-phenyl
B.147 Et 0 4-CH3-S02-phenyl
B.148 Et 1 4-CH3-S02-phenyl
B.149 2-propyl 0 4-CH3-S02-phenyl
B.150 2-propyl 1 4-CH3-S02-phenyl
B.151 N(CH3)2 1 4-CH3-S02-phenyl
B.152 Et 0 3-CH3CO-phenyl
B.153 Et 1 3-CH3CO-phenyl
B.154 2-propyl 0 3-CH3CO-phenyl
B.155 2-propyl 1 3-CH3CO-phenyl
B.156 N(CH3)2 1 3-CH3CO-phenyl
B.157 Et 0 3-CH3OOC-phenyl
B.158 Et 1 3-CH3OOC-phenyl
B.159 2-propyl 0 3-CH3OOC-phenyl
B.160 2-propyl 1 3-CH3OOC-phenyl
B.161 N(CH3)2 1 3-CH3OOC-phenyl
B.162 Et 0 4-N(CH3)2-phenyl
B.163 Et 1 4-N(CH3)2-phenyl
B.164 2-propyl 0 4-N(CH3)2-phenyl
B.165 2-propyl 1 4-N(CH3)2-phenyl
B.166 N(CH3)2 1 4-N(CH3)2-phenyl
B.167 Et 0 3-N02-phenyl
B.168 Et 1 3-N02-phenyl
B.169 2-propyl 0 3-N02-phenyl
B.170 2-propyl 1 3-N02-phenyl
B.171 N(CH3)2 1 3-N02-phenyl
B.172 Et 0 4-CN-phenyl
B.173 Et 1 4-CN-phenyl
B.174 2-propyl 0 4-CN-phenyl
B.175 2-propyl 1 4-CN-phenyl
B.176 N(CH3)2 1 4-CN-phenyl
B.177 Et
Figure imgf000040_0001
0 4-OH-phenyl - 39 -
B.178 Et 1 4-OH-phenyl
B.179 2-propyl 0 4-OH-phenyl
B.180 2-propyl 1 4-OH-phenyl
B.181 N(CH3)2 1 4-OH-phenyl
B.182 Et 0 2-thienyl
B.183 Et 1 2-thienyl
B.184 2-propyl 0 2-thienyl
B.185 2-propyl 1 2-thienyl
B.186 N(CH3)2 1 2-thienyl
B.187 Et 0 3-thienyl
B.188 Et 1 3-thienyl
B.189 2-propyl 0 3-thienyl
B.190 2-propyl 1 3-thienyl
B.191 N(CH3)2 1 3-thienyl
B.192 Et 0 2-f uranyl
B.193 Et 1 2-f uranyl
B.194 2-propyl 0 2-f uranyl
B.195 2-propyl 1 2-f uranyl
B.196 N(CH3)2 1 2-furanyl
B.197 Et 0 1 -naphthyi
B.198 Et 1 1 -naphthyi
B.199 2-propyl 0 1 -naphthyi
B.200 2-propyl 1 1 -naphthyi
B.201 N(CH3)2 1 1 -naphthyi
B.202 Et 0 2-naphthyl
B.203 Et 1 2-naphthyl
B.204 2-propyl 0 2-naphthyl
B.205 2-propyl 1 2-naphthyl
B.206 N(CH3)2 1 2-naphthyl
B.207 Et 0 3-pyridyl
B.208 Et 1 3-pyridyl
B.209 2-propyl 0 3-pyridyl
Figure imgf000041_0001
B.210 2-propyl 1 3-pyridyl - 40 -
B.211 N(CH3)2 1 3-pyridyl
B.212 Et 0 2-benzothiazolyl
B.213 Et 1 2-benzothiazolyl
B.214 2-propyl 0 2-benzothiazolyl
B.215 2-propyl 1 2-benzothiazolyl
B.216 N(CH3)2 1 2-benzothiazolyl
B.217 Et 0 3-indolyl
B.218 Et 1 3-indolyl
B.219 2-propyl 0 3-indolyl
B.220 2-propyl 1 3-indolyl
B.221 N(CH3)2 1 3-indolyl
B.222 Et 0 3-CF3-phenyl
B.223 Et 1 3-CF3-phenyl
B.224 2-propyl 0 3-CF3-phenyl
B.225 2-propyl 1 3-CF3-phenyl
B.226 N(CH3)2 1 3-CF3-phenyl
B.227 Et 0 4-phenoxy-phenyl
B.228 Et 1 4-phenoxy-phenyl
B.229 2-propyl 0 4-phenoxy-phenyl
B.230 2-propyl 1 4-phenoxy-phenyl
B.231 N(CH3)2 1 4-phenoxy-phenyl
B.232 Et 0 4-ethoxy-phenyl
B.233 Et 1 4-ethoxy-phenyl
B.234 2-propyl 0 4-ethoxy-phenyl
B.235 2-propyl 1 4-ethoxy-phenyl
B.236 N(CH3)2 1 4-ethoxy-phenyl
B.237 Et 0 3,4-0-CH2-0-phenyl
B.238 Et 1 3,4-0-CH2-0-phenyl
B.238 2-propyl 0 3,4-0-CH -0-phenyl
B.240 2-propyl 1 3,4-0-CH2-0-phenyl
B.241 N(CH3)2 1 3,4-0-CH2-0-phenyl
B.242 Et 0 3,4-0-CH2CH2-0-phenyl
B.243 Et
Figure imgf000042_0001
1 3,4-0-CH2CH2-0-phenyl - 41 -
B.244 2-propyl 0 3,4-0-CH2CH2-0-phenyl
B.245 2-propyl 1 3,4-0-CH2CH2-0-phenyl
B.246 N(CH3)2 1 3,4-0-CH2CH2-0-phenyl
B.247 Et 0 4-biphenyl
B.248 Et 1 4-biphenyl
B.249 2-propyl 0 4-biphenyl
B.250 2-propyl 1 4-biphenyl
B.251 N(CH3)2 1 4-biphenyl
B.252 Et 0 4-isopropyl-phenyl
B.253 Et 1 4-isopropyl-phenyl
B.254 2-propyl 0 4-isopropyl-phenyl
B.255 2-propyl 1 4-isopropyl-phenyl
B.256 N(CH3)2 1 4-isopropyl-phenyl
B.257 Et 0 4-CH3OOC-phenyl
B.258 Et 1 4-CH3OOC-phenyl
B.259 2-propyl 0 4-CH3OOC-phenyl
B.260 2-propyl 1 4-CH3OOC-phenyl
B.261 N(CH3)2 1 4-CH3OOC-phenyl
B.262 Et 0 3,4-di-F-phenyl
B.263 Et 1 3,4-di-F-phenyl
B.264 2-propyl 0 3,4-di-F-phenyl
B.265 2-propyl 1 3,4-di-F-phenyl
B.266 N(CH3)2 1 3,4-di-F-phenyl
B.267 Et 0 4-tert.butyl-phenyl
B.268 Et 1 4-tert.butyl-phenyl
B.269 2-propyl 0 4-tert.butyl-phenyl
B.270 2-propyl 1 4-tert.butyl-phenyl
B.271 N(CH3)2 1 4-tert.butyl-phenyl
B.272 Et 0 3-CI-phenyl
B.273 Et 1 3-CI-phenyl
B.274 2-propyl 0 3-CI-phenyl
B.275 2-propyl 1 3-CI-phenyl
Figure imgf000043_0001
B.276 N(CH3)2
Figure imgf000043_0002
1 3-CI-phenyl - 42 -
B.277 Et 0 3,5-di-CI-phenyl
B.278 Et 1 3,5-di-CI-phenyl
B.279 2-propyl 0 3,5-di-CI-phenyl
B.280 2-propyl 1 3,5-di-CI-phenyl
B.281 N(CH3)2 1 3,5-di-CI-phenyl
B.282 Et 0 3-pyrazolyl
B.283 Et 1 3-pyrazolyl
B.284 2-propyl 0 3-pyrazolyl
B.285 2-propyl 1 3-pyrazolyl
B.286 N(CH3)2 1 3-pyrazolyl
B.287 Et 0 1 -Me-2-benzimidazolyl
B.288 Et 1 1 -Me-2-benzimidazolyl
B.289 2-propyl 0 1 -Me-2-benzimidazolyl
B.290 2-propyl 1 1 -Me-2-benzimidazolyl
B.291 N(CH3)2 1 1 -Me-2-benzimidazolyl
B.292 Et 0 2-thiazolyl
B.293 Et 1 2-thiazolyl
B.294 2-propyl 0 2-thiazolyl
B.295 2-propyl 1 2-thiazolyl
B.296 N(CH3)2 1 2-thiazolyl
B.297 Et 0 1-Me-3-indolyl
B.298 Et 1 1 -Me-3-indolyl
B.299 2-propyl 0 1 -Me-3-indolyl
B.300 2-propyl 1 1 -Me-3-indolyl
B.301 N(CH3)2 1 1 -Me-3-indolyl
B.302 Et 0 2-pyrrolyl
B.303 Et 1 2-pyrrolyl
B.304 2-propyl 0 2-pyrrolyl
B.305 2-propyl 1 2-pyrrolyl
B.306 N(CH3)2 1 2-pyrrolyl
B.307 Et 0 2-imidazolyl
B.308 Et 1 2-imidazolyl
Figure imgf000044_0001
B.309 2-propyl 0 2-imidazolyl as
OS
P-4 υ
>> >-
C c c c
>< φ φ φ > φ >^ c
>- sz sz sz c z c c c φ >> c CL CL φ e φ φ ex x >- >- Φ sz >- >- sz c c C x: sz sz φ φ Φ
>. >s >- >- >- φ o >- o ό Φ
CL φ c c c c ex c c sz o c
SI ___ Ω. CL CL C sz c- r Φ φ φ φ φ CL
Ω Ω Ω Ω Ω Ω Ω ex X c φ -
N N N N N N N φ X X φ
CL sz x: x: sz x: ex sz X X CL CL 9 9 9 c Έ S. c φ
CO CO CO CO CO CO CO ό 9 sz sz
TJ TJ TJ TJ TJ TJ TJ x 9 9 X cό ex ex IX ex ex ex Ω X o o 9 o 4_ 4_ 4_ φ e cό sz CM
CX ex
LL TJ TJ TJ CJ LL LL 4 LL LL LL ex φ"
Figure imgf000045_0001
E E E E E E E X X X X X φ Ω
9 r~ SZ ό ffl
4 ffl 4 4 z 9 9 9 9 9 9 9 ex Φ 4 Li." UL H". 9 9 9 LL
Figure imgf000045_0003
c ffl
CM CM
Figure imgf000045_0002
4 co" 4 co" co" 4 4 cό cό cό 4 cό cό 4 4 co" cό cό cό cό cό cό cό tf) CM
CO
>s J -. ^ ex ex ex CZO 5 co >- _ ex ex CL ex ex ex ex ex
Ω X Ω Ω X Ω Ω X Ω Ω o X Ω Ω X Ω Ω Ω Ω
Tf X X o O Q. O O
Figure imgf000045_0004
O 3
Q- ^ Q- 9. ex O ex XI so a- ex ro CM LU HI CM CM •Λ LU ÷ HI 9- X O
Tf O LU z' Z LU O UJ UJ 1- C
Os
O O T- CM CO m co Is- co cn o CM CO ^1- in CD Is- 00 cn CM CO in CD Is- 00 cn CM
CM CM CM CM CM CM CM CM CM CoO CO CO CO CO CO CO co CO CO o CO CO CO CO CO co co CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO co co 00 m m CQ CQ CQ ffl' m n ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl m m ffl m m m m m m m m m cQ
44
B.343 vinyl 1 4-Br-phenyl
B.344 4-Me-phenyl 4-Br-phenyl
B.345 Et 1 2-CH30-phenyl
B.346 Et 1 3-CH30-phenyl
B.347 Et 1 2-CI-phenyl
B.348 Et 1 3,5-di-F-phenyl
B.349 Et 1 3-CH3,4-CH30-phenyl
B.350 Et 1 4-NHCOCH3-phenyl
B.351 Et 1 3,5-di-CH30-phenyl
B.352 Et 1 4-pyrrolidino-phenyl
B.353 Et 3-Br-phenyl
B.354 Et 3-CH30,4-propargyloxy-pheny
B.355 Et 4-Br,2-thienyl
B.356 Et 2-fluorenyl
B.357 Et I 4-CH(0-Et)2-phenyl
B.358 Et 1 4-(4'-CI-phenoxy)-phenyl
B.359 Et 1 5-Me,2-furanyl
B.360 Et 1 3-CI-phenyl
B.361 Et 1 4-N02-phenyl
B.362 Et 1 2,4-di-CH30-phenyl
B.363 Et 1 2,4-di-CI-phenyl
B.364 N(CH3)2 1 5-Me,2-furanyl
B.365 N(CH3)2 1 3-F-phenyl
B.366 N(CH3)2 1 5-Me,2-thienyl
B.367 N(CH3)2 1 2-CH30-phenyl
B.368 N(CH3)2 1 3-CH30-phenyl
B.369 N(CH3)2 1 2-CI-phenyl
B.370 N(CH3)2 1 3,5-di-F-phenyl
B.371 N(CH3)2 1 3-CH3,4-CH30-phenyl
B.372 N(CH3)2 1 4-N02-phenyl
B.373 N(CH3)2 1 3,5-di-CH30-phenyl
B.374 N(CH3)2 1 2,4-di-CH30-phenyl
Figure imgf000046_0001
B.375 N(CH3)2 1 2,4-di-CI-phenyl - 45
B.376 N(CH3)2 4-pyrrolidino-phenyl
B.377 N(CH3)2 3-Br-phenyl
B.378 N(CH3)2 3-CH30,4-propargyloxy-phenyl
B.379 N(CH3)2 4-Br,2-thienyl
B.380 N(CH3)2 4-(4'-CI-phenoxy)-phenyl
Figure imgf000047_0002
B.381 N(CH3)2 2-fluorenyl
Preparation Examples for the compounds of formula I:
Example 1. : 2-(4-chloro-phenvl)-N-r2-(3,4-dimethoxv-phenvl)-ethvn-2-ethanesulfonylamino- acetamide
CH3 ° o H H
S — H- ■NH- OCH,
II
O H H
Figure imgf000047_0001
OCH,
Cl
To a vigorously stirred solution of 8 g amino-(4-chloro-phenyl)-acetic acid (J.Chem.Soc.,1962,1440) and 1.7 g sodium hydroxide in 125 ml water at 0°C is added simultaneously a solution of 5.6 g ethanesulfonyl chloride in 100 ml toluene and a solution of 1.7 g sodium hydroxide in 100 mi water during 20 minutes. The reaction mixture is stirred for 45 min at 0°C. Stirring is continued for 3 hours during which the reaction mixture is allowed to warm to room temperature.
The organic phase is separated and extracted with 100 ml 2N sodium hydroxide solution. The water phases are combined and acidified with cone, hydrochloric acid to pH<2 and extracted with ethyl acetate (2x500 ml). The organic phases are washed with brine solution (2x150 ml), dried over magnesium sulfate and evaporated to dryness, yielding (4-chloro- phenyl)-ethanesulfonamino-acetic acid as yellow oil.
To a solution of 2.5 g (4-chloro-phenyl)-ethanesulfonamino-acetic acid, 1.6 g homoveratrylamine and 3.1 ml N,N-diisopropylethylamine in 40 ml N,N-dimethylformamide is added 4 g benzotriazol-1 -yloxy-tris(dimethylamino)phosphonium hexafluorophosphate. The reaction mixture is stirred for 2 hours at room temperature. 500 ml water is added and extracted twice with ethyl acetate (2x300 ml). The organic phases are washed with brine 46
(2x100 ml), combined, died over magnesium sulfate and evaporated to dryness. The residue is purified by flash column chromatography on silica gel using ethyl acetate/hexane 2:1 as eluent. 2-(4-chloro-phenyl)-N-[2-(3,4-dimethoxy-phenyl)-ethyl]-2- ethanesulfonylamino-acetamide is obtained (cmpd. Tab.14,B.3) and recrystallized from ethyl acetate/hexane, m.p. 136-138°C
Example 2. : 2-benzoπ .31dioxol-5-vl-N-r2-(3.4-dimethoxv-phenvl)-ethvll-2-(N',N'- dimethylsulfamido)-acetamide
O H H
N(CH3)2-S — NH OCH, O
Figure imgf000048_0001
A mixture of 4J8 g (25.0 mmol) 4-(2-isocyano-ethyl)-1 ,2-dimethoxy-benzene, 4.5 g (30 mmol) piperonal, 3.15 g (50 mmol) ammonium formiate in 25 ml methanol (which has been previously purged by a nitrogen stream) is heated at reflux for 18 hours. The solution is cooled to 0°C and 10 ml HCI 10M in methanol is added. The reaction mixture is stirred at RT for 10 hours. The mixture is then extracted with 2 fold 150 ml ice-cooled water. The water phase is made basic by the addition of NaOH 2N (pH=14) and is extracted with ethyl acetate. 7.33 g (82%) 2-amino-2-benzo[1 ,3]dioxol-5-yl-N-[2-(3,4-dimethoxy-phenyl)-ethyl]- acetamide is isolated as an orange oil which is further reacted without purification.
1.9 g (5.3 mmol) 2-amino-2-benzo[1 ,3]dioxol-5-yl-N-[2-(3,4-dimethoxy-phenyl)-ethyl]- acetamide is dissolved in 20 ml THF and cooled to 0°C. 0.8 ml (7.42 mmol) N,N-dimethyl- sulfamoyl chloride and 2.22 ml (15.9 mmol) triethylamine are added and the mixture is stirred 15 hours at RT. After dilution with ethyl acetate, the mixture is extracted with ice- cooled water. Evaporation of the solvent give an oil which is crystallized in toluene to give 1.08 g (44%) 2-benzo[1 ,3]dioxol-5-yl-N-[2-(3,4-dimethoxy-phenyl)-ethyl]-2-(N',N'- dimethylsulfamido)-acetamide (cmpd. Tab.14,B.241 ) as a white solid (m.p. 137.5-139°C). From the mother liquor 0.85 g (35%) compound is further isolated.
The compounds given in Table C can be obtained analogously to Examples 1 or 2. 47 -
Table C
Compound Stereochemistry physical data m.p. or M(ESMS)
Tab.2, t .277 R,S 113-115 lab.2, / ^278 R,S 123-124°C
Tab.14 B.3 R,S 136-138°C
Tab.14 B.38 R,S 473(M-1 )-
Tab.14 B.38 R 126-127°C
Tab.14 B.46 R oil
Tab.14 BJ3 R,S 157-159°C
Tab.14 B.77 R,S 167-168.5°C
Tab.14 B.79 R,S 143-145°C
Tab.14 B.81 R,S 497(M-1 )-
Tab.14 B.82 R,S 114-116°C
Tab.14 B.85 R,S 135-136°C
Tab.14 B.88 R,S 118.5-119.5°C
Tab.14 B.91 R,S 116-127°C; 437(M+1 )+
Tab.14 B.94 R,S 452(M+1 )+
Tab.14 B.97 R,S 150-153°C
Tab.14 B.103 R,S 161 -163°C
Tab.14 B.109 R,S 154-155°C
Tab.14 B.112 R,S 506(M+1 )+
Tab.14 B.143 R,S 155.5-156.5°C
Tab.14 B.146 R,S 102.5-104.5°C
Tab.14 B.163 R,S 146-148°C
Tab.14 B.166 R,S 109-110°C
Tab.14 B.173 R,S 145-147°C
Tab.14 B.176 R,S 445(M-1 )-
Tab.14 B.183 R,S 136-137.5°C
Tab.14 B.186 R,S 426(M-1 )-
Tab.14 B.193 R,S 395(M-1 )-
Figure imgf000049_0001
Tab.14 B.196
Figure imgf000049_0002
R,S 410(M-1 )- 48 -
Tab.14, B.198 R,S 144-146°C
Tab.14, B.201 R,S 470(M-1 )-
Tab.14, B.203 R,S 135-136.5°C
Tab.14, B.206 R,S 472(M+1 )+
Tab.14, B.223 R,S 103-107°C
Tab.14, B.228 R,S 134-136°C
Tab.14, B.231 R,S 128.5-131 °C
Tab.14, B.233 R,S 137.5-138.5°C
Tab.14, B.236 R,S 119-121
Tab.14, B.238 R,S 188-189.5°C
Tab.14, B.241 R,S 137.5-139°C
Tab.14, B.248 R,S 144-144.5°C; 483(M+1 )+
Tab.14, B.251 R,S 125-126.5°C; 498(M+1 )+
Tab.14, B.253 R,S 163-164°C
Tab.14, B.256 R,S 464(M+1 )+
Tab.14, B.258 R,S 140-141.5°C; 465(M+1 )+
Tab.14, B.261 R,S 126-127°C; 480(M+1 )+
Tab.14, B.263 R,S 149.5-151 °C
Tab.14, B.266 R,S 458(M+1 )+
Tab.14, B.268 R,S 174-176°C
Tab.14, B.271 R,S 476(M-1 )-
Tab.14, B.273 R,S 123-125°C
Tab.14, B.276 R,S 117-118°C; 456(M+1 )+
Tab.14, B.278 R,S 120.5-122°C
Tab.14, B.281 R,S 155-157°C
Tab.14, B.317 R,S 115.5-1 18.5°C
Tab.14, B.318 R,S 159.5-160.5°C
Tab.14, B.319 R,S 136-137°C
Tab.14, B.320 R,S 142-143°C
Tab.14, B.321 R,S 139-141 °C
Tab.14, B.322 R,S 125.5-126.5°C
Tab.14, B.323 R,S 130.5-135.5°C
Figure imgf000050_0001
Tab.14, B.324 R,S 112.5-1 13.5°C OS O a.
63 Hυ 0.
O
O o Oo in m
O -tf O O o O co 0 oo oo ~a. . ^ cn ■tf Oo h» o CD CM CO Is- o T- - T- CM in Is-
•r- o CO ■-tf ■-tf CM
2 2 + V CD + in m in in ι— «£ **
"tf CO
CO CO 00 Is- CM •<tf cn CM in oo m h- CM CD Is- 1- CO Is- co co CM ^ — CM co CO 00 00 CO CO co CO CM o CM CM Is- C-M÷
Figure imgf000051_0002
in CO co co "tf -tf m CO Is- CO cn cn "tf in
Figure imgf000051_0001
"tf "tf -tf "tf 00 s— T- tf -tf -tf tf "tf
Figure imgf000051_0003
-tf "tf ■tf "tf -tf "tf •tf "tf ■tf
O)
■-tf
ω co co co co co co co co co co ω ω co co co co co co co co co co co co co co ω co co co co co cf cf cf f f cf cf tf cf cf cf f f cf tf cf cf cf cf cf cf cf cf cf cf cf cf cf cf cf cf tf tf
ro in CO Is- 00 en o CM co "tf m CD Is- CO cn o CM co ^1- m co Is- 00 O) CM co "tf m O) o
CM CM CM CM CM CO CO CO CO CO CO CO CO CO CO -tf "tf "tf -tf "tf "tf "tf "tf "tf m m in m m in CD co CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO 5 CO co CO co 00 co CO CO 00 CO CO CO CO CO CO CO CO o ffl ffl ffl ffl ffl m ffl ffl ffl ffl ffl m ffl ffl ffl m ffl ffl ffl ffl ffl ffl ffl m ffl ffl ffl ffl ffl ffl CQ ffl ffl
"t -tf "tf ■tf ■tf ■tf- "tf •tf- "tf "tf "tf "tf "tf "tf "tf "tf "tf "tf "tf "tf ■-tf "tf "tf "tf "tf "tf "tf "tf "tf "tf "tf -tf •tf
XI Z. XI XI Si XI XI Si -Ω X3 X) zx X) XI xa 3 J XI X3 X) X) XI XI X) XI XI XI X) X) X) XI XI XI CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO O CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO
Figure imgf000051_0004
H h- 1— h- H i— H 1— I- 1- H 1- 1- 1- 1- 1— h- I— 1- H 1- 1- h- 1- 1- I— 1-
Os as
υ
X X X X X X X X X X X X X X X X X O O O O O n + + + + + + n + +
^—
+ + + + + + + + + + + + + + + + + S c^ S S cS 9 in ^— ^— ^—
+ + en
"tf + + + + in + +
Έ Έ Έ ≥ 2> ≥ :>
N tO lO O N N N tO ffl lO N N N T- tD N ffi N ^ s i ό r o CO Is- cn Is- CM CO CO co ιs- cM -tf -tf in ιn m ιn co co oo co cn o θ "tf τtf CM "tf m cD "tf -tf CD co o cn co O in tf) m
■tf- "-tf 'tf- 'tf '-tf "tf ,-tf 'tf- ,-tf "tf --tf "tf- ,-tf 'tf in in in 'r- - -ι- r- 'l- τ-
Figure imgf000052_0001
•tf -tf in -tf •tf- in ι— "tf -tf o in
co co ω co co co co co co co co co ω co ω co co co co co co co co co co co co co co co co co co x x cf cf cf cf cf cf cf f tf cf cf cf cf cf cf cf cf cf tf cf cf cf cf αf cf cf cf tf tf tf tf
Tf Tf so ro CM 00 •tf m CD Is- 00 cn o CM CO -tf ιn co cn o co co 00 00 co CO "tf cn o
CD CD co CO CO CD CO CO Is- Is- h- - r- Is- - Is- 00 00 ιn r- o cn tf in Is- r-- CO CO ■tf-
CO CO CO CO CO CO CO CO 00 co 00 co co 00 00 00 CO co Is- co cn cn co cn ι— CM CM CM CM CO CO co
Os ffl Q ffl m CQ ffl ffl ffl ffl CQ ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl CQ O ffl ffl ffl ffl ffl ffl
O
"tf "tf "tf •tf TI- "tf -tf ■tf "tf •tf- Tt- ■tf •tf- -tf M- "tf -tf m m in in m in CO CO CD CD CO CD CD CO CO CD
X) _α .Ω X) X) Ω _Ω XI Ω XI X) X) XI XI X) -Ω XI XI XI Si xι XI XI XI .Ω XI Si ,Ω XI Si Q X) XI
CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO o CO CO CO CO CO CO CO CO CO CO CO
Figure imgf000052_0002
h- h- 1- !— H h- 1- h- 1- - i— - 1- 1- h- H 1- 1- - h- h- 1- I— - t- h- 1- 1- h- H \- 1- h-
-51 -
Tab.16, B.345 R,S 463(M+1)+
Tab.16, B.346 R,S 463(M+1)+
Tab.16, B.347 R,S 467( +1)+
Tab.16, B.348 R,S 469( +1)+
Tab.16, B.349 R,S 478(M+1)+
Tab.16, B.350 R,S 490(M+1)+
Tab.16, B.351 R,S 493( +1)+
Tab.16, B.352 R,S 502(M+1)+
Tab.16, B.353 R,S 512(M+1)+
Tab.16, B.354 R,S 517(M+1)+
Tab.16, B.355 R,S 518(M+1)+
Tab.16, B.356 R,S 521(M+1)+
Tab.16, B.357 R,S 535(M+1)+
Tab.16, B.358 R,S 560(M+1)+
Tab.16, B.362 R,S 493(M+1)+
Tab.17, B.1 R oil
Tab.17, B.3 R,S 123-128°C
Tab.17, B.3 R 126-127
Tab.17, B.3 S oil
Tab.17, B.11 R oil
Tab.17, B.79 R,S 144-145°C
Tab.17, B.82 R,S 115.5-117.5°C
Tab.17, B.85 R,S 139.5-140.5°C
Tab.17, B.88 R,S 96-97.5°C
Tab.17, B.91 R,S 461(M+1)+
Tab.17, B.94 R,S 476(M+1)+
Tab.17, B.248 R,S 507(M+1)+
Tab.17, B.251 R,S 520(M-1)-;522(M+1)
Tab.17, B.258 R,S 489(M+1)+
Tab.17, B.261 R,S 504(M+1)+
Tab.17, B.273 R,S 480(M+1)+
Tab.17, B.334 R,S 135-137°C
Tab.17, B.339
Figure imgf000053_0001
R,S 449(M+1)+ -52-
Tab.17, B.340 R,S 451(M+1)+
Tab.17, B.345 R,S 461(M+1)+
Tab.17, B.346 R,S 461( +1)+
Tab.17, B.347 R,S 465(M+1)+
Tab.17, B.348 R,S 467(M+1)+
Tab.17, B.349 R,S 475(M+1)+
Tab.17, B.350 R,S 488(M+1)+
Tab.17, B.351 R,S 491(M+1)+
Tab.17, B.352 R,S 500( +1)+
Tab.17, B.353 R,S 510(M+1)+
Tab.17, B.354 R,S 515(M+1)+
Tab.17, B.355 R,S 516(M+1)+
Tab.17, B.356 R,S 519(M+1)+
Tab.17, B.358 R,S 558(M+1)+
Tab.17, B.359 R,S 435(M+1)+
Tab.17, B.360 R,S 465(M+1)+
Tab.17, B.361 R,S 476(M+1)+
Tab.17, B.362 R,S 491(M+1)+
Tab.17, B.363 R,S 500( +1)+
Tab.17, B.364 R,S 450(M+1)+
Tab.17, B.365 R,S 464(M+1)+
Tab.17, B.366 R,S 466(M+1)+
Tab.17, B.367 R,S 476(M+1)+
Tab.17, B.368 R,S 476(M+1)+
Tab.17, B.369 R,S 480(M+1)+
Tab.17, B.370 R,S 482(M+1)+
Tab.17, B.371 R,S 490(M+1)+
Tab.17, B.372 R,S 491(M+1)+
Tab.17, B.373 R,S 506(M+1)+
Tab.17, B.374 R,S 506(M+1)+
Tab.17, B.375 R,S 515(M+1)+
Tab.17, B.376 R,S 515(M+1)+
Tab.17, B.377 R,S 525(M+1)+ -53
Tab.17 B.378 R,S 530( +1)+ Tab.17 B.379 R.S 531(M+1)+ Tab.17 B.380 R,S 573(M+1)+ Tab.18 B.3 diastereomere A 477(M-1)-
(rac.)
Tab.18 B.3 diastereomere B 477(M-1)-
(rac.)
Tab.18 B.38 R.S 130-132°C Tab.18 B.85 R,S 141.5-143.5°C/459(M+1)+ Tab.18 B.88 R,S 110.5-113.5°C/474(M+1)+ Tab.18 B.319 R.S 161-163°C Tab.20 B.3 R,S 140-143°C Tab.21 B.3 R,S 121-123°C Tab.21 B.88 R,S 119.5-121.5°C Tab.21 B.91 R,S 489(M+1)+ Tab.21 B.94 R,S 504(M+1)+ Tab.21 B.258 R,S 517(M+1)+ Tab.21 B.261 R,S 532(M+1)+ Tab.21 B.319 R,S 110-112°C Tab.21 B.334 R,S 127-128°C Tab.21 B.339 R,S 477(M+1 )+ Tab.21 B.340 R,S 479(M+1)+ Tab.21 B.345 R,S 489( +1)+ Tab.21 B.347 R,S 494(M+1)+ Tab.21 B.348 R,S 495(M+1)+ Tab.21 B.349 R,S 503(M+1)+ Tab.21 B.351 R,S 519(M+1)+ Tab.21 B.352 R,S 528(M+1)+ Tab.21 B.353 R,S 538(M+1)+ Tab.21 B.354 R,S 543(M+1)+ Tab.21 B.355 R,S 544(M+1)+ Tab.21 B.356 R,S 547(M+1)+ Tab.21 B.358 R,S 586(M+1)+ 54
Tab.21, B.359 R,S 463(M+1)+
Tab.21, B.361 R,S 504(M+1)+
Tab.21, B.362 R,S 519(M+1)+
Tab.21, B.363 R,S 528(M+1)+
Tab.21, B.364 R,S 478( +1)+
Tab.21, B.365 R,S 492(M+1)+
Tab.21, B.366 R,S 494(M+1)+
Tab.21 , B.367 R,S 504(M+1)+
Tab.21, B.368 R,S 504(M+1)+
Tab.21, B.369 R,S 509(M+1)+
Tab.21, B.370 R,S 510(M+1)+
Tab.21, B.371 R,S 518(M+1)+
Tab.21, B.372 R,S 519(M+1)+
Tab.21, B.373 R,S 534(M+1)+
Tab.21, B.374 R,S 534(M+1)+
Tab.21, B.376 R,S 543(M+1)+
Tab.21, B.377 R,S 553(M+1)+
Tab.21 , B.378 R,S 558(M+1 )+
Tab.21, B.379 R,S 559(M+1)+
Tab.21, B.381 R,S 562(M+1)+
Tab.24, B.3 R,S 119-127°C
Tab.25, B.3 R,S 143-149°C
Tab.27, B.3 diastereomere A 587(M-1)- (rac.)
Tab.27, B.3 diastereomere B 587(M-1)- (rac.)
Tab.30, B.3 R,S oil
Tab.30, B.334 R,S 135-137°C
Tab.32, B.3 R,S 142-144°C
Tab.32, B.334 R,S 156-157°C
Tab.36, B.3 R,S 171-178°C
Tab.40, B.3 R,S 151-158°C
Figure imgf000056_0001
Tab.47, B.3 R,S 145-147°C 55 -
Tab.48, B.3 R,S 156-158°C Tab.49, B.3 R,S 144-148°C Tab.50, B.3
Figure imgf000057_0001
R,S 123-126°C
(M(ESMS) = ion peaks in electrospray massspectrometry)
Table D (Ugi intermediates) R2 .0
NH„- Jj (VI)
R„ NH-
(Me means methyl)
No. R2 R3 A B phys. data m.p.°C
D1 H 4-CI,3-F-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D2 H 4-CI,3-CF3-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D3 H 4-CI,3-F-phenyl -CH2CH2- 4-n-butylO,3-MeO- 94-97 phenyl
D4 H 3,4-di-CI-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D5 H 4-Br-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D6 H 4-Me-phenyl -CH CH2- 3,4-di-MeO-phenyl 95-97
D7 H 4-CF30-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D8 H 3,4-di- eO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D9 H 4-N(Me)2-phenyl -CH CH2- 3,4-di-MeO-phenyl oil
D10 H 4-MeS-phenyl -CH2CH2- 3,4-di-MeO-phenyl 71 -75
D11 H 3-Me-phenyl -CH2 H2- 3,4-di-MeO-phenyl oil
D12 H 3-CF3-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D13 H 4-PhO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D14 H 4-EtO-phenyl -CH2CH2- 3,4-di-MeO-phenyl 100-102
D15 H 3,4-(OCH20)-phenyl -CH CH2- 3,4-di-MeO-phenyl oil
D16 H 4-Ph-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D17 H 4-i-propyl-phenyl -CH2CH - 3,4-di-MeO-phenyl 87-91
D18 H 4-(C00Me)-phenyl -CH2CH2- 3,4-di-MeO-phenyl 99-101
Figure imgf000057_0002
D19 H 3,4-di-F-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil - 56 -
D20 H 4-tert.butyl-phenyl -CH2CH2- 3,4-di-MeO-phenyl 83-87
D21 H 4-CN-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D22 H 3-CI-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D23 H 1 -naphthyi -CH2CH2- 3,4-di-MeO-phenyl oil
D24 H 3,5-di-CI-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D25 H 2-thienyl -CH2CH2- 3,4-di-MeO-phenyl oil
D26 H 4-CI-phenyl -CH CH2- 3-MeO,4-propargylO- oil phenyl
D27 H 2-furanyl -CH2CH2- 3,4-di-MeO-phenyl oil
D28 H 4-Ph-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D29 H 4-CI-phenyl -CH(CH3)CH2- oil
D30 H 4-Br-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D31 H 4-Me-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D32 H 4-Br-phenyl -CH2CH2- 3-Me0,4-(pent-2'-in-1'- oil yloxy)-phenyl
D33 H 4-Me-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D34 H 2-naphthyl -CH2CH2- 3,4-di-MeO-phenyl oil
D35 H 3,4-di-CI-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D36 H 4-Me-phenyl -CH(CH3)CH2- 3-MeO,4-propargylO- oil phenyl
D37 H 5-Me, 2-furanyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D38 H 3-F-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D39 H 5-Me,2-thienyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D40 H 4-MeO-phenyl -CH2CH - 3-MeO,4-allyO-phenyl oil
D41 H 2-MeO-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D42 H 3-CI-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D43 H 2-CI-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
Figure imgf000058_0001
D44 H 3,5-di-F-phenyl -CH2CH2- 3-Me0,4-ally0-phenyl oil 57
D45 H 3-Me,4-MeO-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D46 H 4-N-acetylamino-phenyl -CH2CH2- 3-Me0,4-ally0-phenyl oil
D47 H 4-(COOMe)-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D48 H 3,5-di-MeO-phenyl -CH2CH2- 3-Me0,4-ally0-ρhenyl oil
D49 H 2,4-di-MeO-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D50 H 2,4-di-CI-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D51 H 3-(N-pyrrolidino)-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D52 H 4-Ph-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D53 H 3-Br-phenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D54 H 3-MeO,4-propargylO- -CH2CH2- 3-Me0,4-ally0-phenyl oil phenyl
D55 H 3-Br,2-thienyl -CH2CH2- 3-Me0,4-ally0-phenyl oil
D56 H 3-fluorenyl -CH2CH2- 3-MeO,4-allyO-phenyl oil
D57 H 3-(4'-CI-PhO)-phenyl -CH2CH2- 3-Me0,4-ally0-phenyl oil
D58 H 5-Me,2-furanyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D59 H 3-F-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D60 H 5-Me,2-thienyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D61 H 4-MeO-phenyl -CH CH2- 3-MeO,4-propargylO- oil phenyl
D62 H 2-MeO-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D63 H 3-MeO-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D64 H 3-CI-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D65 H 2-CI-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D66 H 3,5-di-F-phenyl -CH2CH2- 3-MeO,4-propargylO- oil
Figure imgf000059_0001
phenyl - 58 -
D67 H 3-Me,4-Me0-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D68 H 4-N02-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D69 H 4-N-acetylamino-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D70 H 4-(COOMe)-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D71 H 3,5-di-MeO-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D72 H 2,4-di-CI-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D73 H 4-(N-pyrrolidino)-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D74 H 3-Br-phenyl -CH2CH2 3-MeO,4-propargylO- oil phenyl
D75 H 3-MeO,4-propargylO- -CH2CH2- 3-MeO,4-propargylO- oil phenyl phenyl D76 H 4-Br,2-thienyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D77 H 3-fluorenyl -CH2CH2 3-MeO,4-propargylO- oil phenyl
D78 H 4-(4'-CI-Ph0)-ρhenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D79 H 2,4-di-MeO-phenyl -CH2CH2- 3-MeO,4-propargylO- oil phenyl
D80 H 5-Me,2-furanyl -CH2CH2- 3-Me0,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D81 H 3-F-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D82 H 5-Me,2-thienyl -CH2CH2- 3-Me0,4-(pent-2'-in-1 '- oil yloxy)-phenyl 59
D83 H 4-MeO-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D84 H 2-MeO-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D85 H 3-MeO-phenyl -CH2CH2- 3-Me0,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D86 H 2-CI-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D87 H 3,5-di-F-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D88 H 3-Me,4-MeO-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D89 H 4-N02-phenyl -CH2CH2- 3-Me0,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D90 H 4-(COOMe)-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D91 H 3,5-di-MeO-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D92 HG 2,4-di-MeO-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D93 H 2,4-di-CI-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D94 H 4-(N-pyrrolidino)-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1'- oil yloxy)-phenyl
D95 H 3-Br-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D96 H 3-MeO,4-propargylO- -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil phenyl yloxy)-phenyl D97 H 4-Br,2-thienyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D98 H 3-fluorenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl 60
D99 H 4-(4'-CI-PhO)-phenyl -CH2CH2- 3-MeO,4-(pent-2'-in-1 '- oil yloxy)-phenyl
D100 H 5-Me, 2-furanyl -C 2CH2- 3,4-di-MeO-phenyl oil
D101 H 3-F-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D102 H 5-Me,2-thienyl -CH2CH2- 3,4-di-MeO-phenyl oil
D103 H 4-MeO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D104 H 2-MeO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D105 H 3-MeO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D106 H 2-CI-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D107 H 3,5-di-F-phenyl -CH2CH2" 3,4-di-MeO-phenyl oil
D108 H 3-Me,4-MeO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D109 H 4-N0 -phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D110 H 4-(N-acetylamino)- -CH2CH2- 3,4-di-MeO-phenyl oil phenyl
D111 H 3,5-di-MeO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D112 H 2,4-di-MeO-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D113 H 2,4-di-CI-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D114 H 4-(N-pyrrolidino)-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D115 H 3-Br-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
D1 16 H 3-MeO,4-propargylO- -CH2CH2- 3,4-di-MeO-phenyl oil phenyl
D117 H 4-Br,2-thienyl -CH2CH - 3,4-di-MeO-phenyl oil
D118 H 3-fluorenyl -CH2CH2- 3,4-di-MeO-phenyl oil
Figure imgf000062_0001
D119 H 4-(4'-CI-PhO)-phenyl -CH2CH2- 3,4-di-MeO-phenyl oil
- 61 -
Formulation Examples for compounds of formula I
Working procedures for preparing formulations of the compounds of formula I such as Emulsifiable concentrates, Solutions, Granulates, Dusts and Wettable powders are described in WO 97/33890.
Biological Examples
B-1 : Action against Plasmopara viticola on vines a) Residual-protective action
Vine seedlings are sprayed at the 4- to 5-leaf stage with a spray mixture (0.02% active ingredient) prepared from a wettable powder formulation of the test compound. After 24 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation for 6 days at 95-100% relative humidity and 20°C. b) Residual-curative action
Vine seedlings are infected at the 4- to 5-leaf stage with a sporangia suspension of the fungus. After incubation for 24 hours in a humidity chamber at 95-100% relative humidity and 20°C, the infected plants are dried and sprayed with a spray mixture (0.02% active ingredient) prepared from a wettable powder formulation of the test compound. After the spray coating has dried, the treated plants are placed in the humidity chamber again. Fungus infestation is evaluated 6 days after infection.
Compounds of Tables 1 to 50 exhibit a very good fungicidal action against Plasmopara viticola on vines. Compounds Tab.14,B.203; Tab.14,B.319; Tab.14,B.335; Tab.14,B.336; Tab.15,B.3; Tab.17,B.1 ; Tab.17,B.3; Tab.17,B.82; Tab.17,B.88; Tab.17,B.251 ; Tab.21 , B.3; Tab.21 ,B.88; Tab.21 ,B.319; Tab.24,B.3 and others virtually completely inhibit fungal infestation (0 to 10% infestation) in this test. On the other hand, Plasmopara infestation on untreated and infected control plants is 100%.
B-2: Action against Phytophthora on tomato plants a) Residual-protective action
After a cultivation period of 3 weeks, tomato plants are sprayed with a spray mixture (0.02% active ingredient) prepared from a wettable powder formulation of the test compound. After
48 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus - 62 -
infestation is evaluated after incubation of the infected plants for 4 days at 90-100% relative humidity and 20°C. b) Systemic action
After a cultivation period of 3 weeks, tomato plants are watered with a spray mixture (0.02% active ingredient based on the volume of the soil) prepared from a wettable powder formulation of the test compound. Care is taken that the spray mixture does not come into contact with the parts of the plants which are above ground. After 4 days, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4days at 90-100% relative humidity and 20°C.
Compounds of Tables 1 to 50 exhibit a lasting effect (less than 20% fungus infestation). Infestation is prevented virtually completely (0 to 5% infestation) with compounds Tab.14,B.112; Tab.14,B.203; Tab.14,B.335; Tab.14,B.336; Tab.15,B.3; Tab.17,B.1 ; Tab.17,B.3; Tab.17,B.82; Tab.17,B.85; Tab.17,B.88; Tab.17,B.251 ; Tab.18,B.3; Tab.21 , B.3; Tab.21 , B.88; Tab.21 , B.319 and others. On the other hand, Phytophthora infestation on untreated and infected control plants is 100%.
B-3 : Action against Phytophthora on potato plants a) Residual-protective action
2-3 week old potato plants (Bintje variety) are sprayed with a spray mixture (0.02% active ingredient) prepared from a wettable powder formulation of the test compound. After 48 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4 days at 90-100% relative humidity and 20°C. b) Systemic action
2-3 week old potato plants (Bintje variety) are watered with a spray mixture (0.02% active ingredient based on the volume of the soil) prepared from a wettable powder formulation of the test compound. Care is taken that the spray mixture does not come into contact with the parts of the plants which are above ground. After 48 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4 days at 90-100% relative humidity and 20°C. - 63 -
Compounds of Tables 1 to 50 exhibit a lasting effect (less than 20% fungus infestation). Infestation is prevented virtually completely (0 to 5% infestation) with compounds Tab.14,B.38; Tab.14,B.203; Tab.14,B.319; Tab.15,B.3; Tab.17,B.1 ; Tab.17,B.3; Tab.17,B.82; Tab.17,B.85; Tab.17,B.88; Tab.17,B.251 and others. On the other hand, Phytophthora infestation on untreated and infected control plants is 100%.

Claims

- 64 -What is claimed is:
1. A compound of formula O R2 O
R, ΓÇö S ΓÇö NH- ij (I)
(0)n R3 NHΓÇö A B
wherein n is the number zero or one;
Ri. is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl; or a group NRaRb wherein Ra and Rb are each independently of the other hydrogen, alkyl or form together an alkylene bridge;
R2 is hydrogen or alkyl;
R3 is optionally substituted aryl or heteroaryl;
A is alkylene; and
B is optionally substituted aryl; with the exception of the following compounds
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-methylphenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-chlorophenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-nitrophenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-(4-methoxyphenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1-phenyl-ethyl)-2-(4-fluorophenyl)-sulfonylamino-acetamide,
2-phenyl-N-(1 -phenyl-ethyl)-2-phenyl-sulfonylamino-acetamide and
2-phenyl-N-(1-phenyl-ethyl)-2-methane-sulfonylamino-acetamide.
2. A compound of formula I according to claim 1 , wherein n is the number zero or one;
R< is C C10alkyl, C2-C10alkenyl, C2-C10alkynyl, C3-C8cycloalkyl, Cs-C╬▓Cycloalkyl-d-CealkyI, C6-C10aryl, or C6-C10aryl-C╬╣-C6alkyl that are optionally mono- or poly-substituted by C C8alkyl, CrC8alkoxy, C Csalkylthio, CrC╬▓alkylsulfonyl, C3-C8cycloalkyl, CrC8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C3-C8cycloalkyl- C<-C6alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8alkenyloxy, C3-C8alkynyloxy, CrC╬▓alkanoyl (where all these alkyl, alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated), halogen, cyano or nitro; or a group NRaRb, wherein Ra and Rb are each independently of the other hydrogen, C╬╣-C8alkyl or together are C2-C alkylen; - 65 -
R2 is hydrogen or d-C8alkyl;
R3 is phenyl, naphthyi or heteroaryl formed by 1 or 2 five- or six-membered rings containing 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur and are optionally mono- or poly-substituted by C╬╣-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C╬╣-C8alkoxy, C C8alkylthio, C╬╣-C8alkylsulfonyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C╬╣-C6alkyl, C╬╣-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C╬╣-C4alkylendioxy, C3-C8cycloalkyloxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C C8alkanoyl, d-C8dialkylamino, C C8alkylamino (where all these alkyl alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated), halogen, nitro, cyano, hydroxy or amino; A is C C8alkylen; and
B is phenyl optionally mono- or poly-substituted by C╬╣-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, CrC8alkoxy, C C8alkylthio, d-C8alkylsulfonyl, C3-C8cycloalkyl, Cs-Cscycloalkyl-d-Cealkyl, d-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C-3-Cacycloalkyloxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C C8alkanoyl, d-C8dialkylamino, d-C8alkylamino, C6-C10aryloxy, C6-C╬╣oaryl-d-C6alkoxy, C6-C10aryl-C╬╣-C6alkenyloxy, Ce-doaryl-CrCealkynyloxy, d-C8alkanoyloxy (where all these alkyl alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated and where all aryl containing groups may be optionally mono- or poly-substituted by C C8alkyl, C2-C8alkenyl C3-C8cycloalkyl, C C8alkoxy, C╬╣-C8alkylthio, C C8alkoxycarbonyl CrC╬▓halogenalkyI, d-C8halogenalkoxy, d-C8halogenthioalkyl, halogen nitro or cyano), halogen, nitro, cyano, hydroxy, amino or the phenyl group may be substituted in two adjacent positions by d-C4alkylenedioxy wherein the alkylene part may be substituted by halogen.
3. A compound of formula I according to claim 2, wherein n is the number zero or one;
Ri is d-C╬╣0alkyl C2-C10alkenyl, C3-C8cycloalkyl that are optionally mono- or poly-substituted by C╬╣-C8alkyl, C╬╣-C8alkoxy, d-C8alkylthio, C C8alkanoyl, C╬╣-C8alkoxycarbonyl, d-C8halogenalkyl, C╬╣-C8halogenalkoxy, C╬╣-C8halogenalkylthio, halogen, nitro or cyano; or a group NRaRb, wherein Ra and Rb are each independently of the other hydrogen, d-C8alkyl, or together are tetramethylene or pentamethylene;
R2 is hydrogen or methyl;
R3 is phenyl, naphthyi, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, pyridyl, pyrimidinyl, benzothiophenyl, benzothiazolyl, chinolinyl, pyrazolyl, indolyl, benzimidazolyl or pyrrolyl optionally substituted by 1 to 3 substituents selected from d-C8alkyl, C2-C8alkenyl, - 66 -
C3-C8cycloalkyl, d-C8alkoxy, C╬╣-C8alkylthio, d-C8alkoxycarbonyl, C╬╣-C8halogenalkyl, d-C8halogenalkoxy, C C8halogenalkylthio, halogen, hydroxy, nitro or cyano; A is d-dalkylen; and
B is phenyl optionally substituted by 1 to 3 substituents selected from d-C8alkyl, C╬╣-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, phenyl-CrC6alkyloxy, phenyl-C3- C6alkenyloxy, phenyl-C3-C6alkynyloxy, C C8alkylthio, d-C8alkoxycarbonyl, C╬╣-C8halogenalkoxy, C3-C8halogenalkenyloxy, halogen, hydroxy, nitro or cyano (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from C╬╣-C8alkyl, C C8alkoxy, C╬╣-C8alkylthio, d-C8halogenalkyl, d-C8halogenalkoxy, d-C8halogenthioalkyl, halogen or cyano).
4. A compound of formula I according to claim 3, wherein n is the number one;
Ri is C╬╣-C6alkyl, C2-C╬╣0alkenyl, C5-C6cycloalkyl, that are optionally mono- or poly-substituted by C C8alkyl, C C8alkoxy, C╬╣-C8alkoxycarbonyl, d-C8halogenalkyl, d-C8halogenalkoxy, halogen or cyano; or a group NRaRb, wherein Ra and Rb are each independently of the other methyl or ethyl;
R2 is hydrogen;
R3 is phenyl optionally substituted by 1 to 3 substituents selected from C╬╣-C8alkyl,
C2-C8alkenyl, C3-C8cycloalkyl, C╬╣-C8alkoxy, C C8alkylthio, C C8alkoxycarbonyl,
C C8halogenalkyl, d-C8halogenalkoxy, CrC8halogenthioalkyl, halogen, hydroxy, nitro or cyano;
A is ethylen; and
B is phenyl optionally substituted by 2 to 3 substituents selected from d-C8alkyl, d-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, phenyl-d-C6alkyloxy, phenyl-C3-
C6aikenyloxy, phenyl-C3-C6alkynyloxy, d-C8alkylthio, C C8alkoxycarbonyl,
CrC8halogenalkoxy, C3-C8halogenalkenyloxy, halogen, hydroxy, nitro or cyano (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from d-C8alkyl, C C8alkoxy, d-C8alkylthio, d-C8halogenalkyl, CrC8halogenalkoxy,
CrC8halogenthioalkyl, halogen or cyano).
5. A compound of formula I according to claim 4, wherein n is the number one; - 67 -
Ri is d-dalkyl optionally mono- or poly-substituted by fluorine, chlorine, bromine or dimethylamin;
R2 is hydrogen;
R3 is phenyl optionally substituted by 1 to 3 substituents selected from d-C8alkyl,
C2-C8alkenyl, C3-C8cycloalkyl, d-C8alkoxy, d-C8alkylthio, C C8alkoxycarbonyl, d-C8halogenalkyl, C C8halogenalkoxy, d-C8halogenthioalkyl, halogen, nitro or cyano;
A is ethylen; and
B is a group
Figure imgf000069_0001
0-RQ
wherein
R8 is d-C alkyl, and
R9 is d-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, phenyl-CrC6alkyl, phenyl-C3-C6alkenyl, phenyl-
C3-C6alkynyl, d-C8halogenalkyl, C3-C8halogenalkenyl (where all phenyl containing groups may be optionally substituted by 1 to 3 substituents selected from d-C8alkyl, d-C8alkoxy, d-C8alkylthio, C C8halogenalkyl, CrC8halogenalkoxy, d-C8halogenthioalkyl, halogen or cyano).
6. A process for the preparation of a compound of formula I according to claim 1 , which comprises a) reacting an amino acid of formula II or a carboxy-activated derivative of an amino acid of formula II
O R
II
R; -S-NH- -COOH (II)
(Q)n R3
with an amine of the formula V H2NΓÇö AΓÇö B (V); or
b) reacting a sulfonyl halide or sulfinyl halide of formula - 68 -
0
II R. ΓÇö S-X (III)
1 II
(0)n where X is halide, with an amino acid derivative of formula VI R2 O
H2N- i (VI) ; and optionally
Ro NH-A-B
c) oxidizing a compound of formula I wherein n = 0 and wherein R<, R2, R3, A and B have the meaning as defined for formula I to a compound of formula I wherein n = 1.
7. A composition for controlling and preventing infestation of plants by microorganisms, which comprises as active ingredient a compound of formula I according to claim 1 , together with a suitable carrier.
8. A method of controlling and preventing infestation of plants by microorganisms, which comprises applying a compound of formula I as active ingredient to the plant, to parts of the plant or to the nutrient medium of the plant.
9. A method according to claim 8, which comprises treating seed.
10. The use of a compound of formula I as a microbicide.
11. The intermediate of formula VI
R2 o
H2N- (VI)
R3 NH-A-B
wherein R2, R3, A and B are as defined in formula I.
12. A process for the preparation of a compound of formula VI according to claim 12, which comprises d) hydrolizing a compound of formula X - 69 -
(X)
Figure imgf000071_0001
under acidic or basic conditions at a temperature between 0┬░ and 100┬░C, wherein R2, R3, A and B have the meaning as defined for formula I and wherein R10 is lower alkyl or hydrogen.
PCT/EP1999/001216 1998-02-27 1999-02-25 N-sulphonyl and n-sulphinyl phenylglycinamide___________________ WO1999043644A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AT99911707T ATE231489T1 (en) 1998-02-27 1999-02-25 N-SULPHONYL AND N-SULPHINYL PHENYLGLYCINAMIDE
JP2000533403A JP2002504536A (en) 1998-02-27 1999-02-25 N-sulfonyl and N-sulfinylphenylglycinamide
EP99911707A EP1071660B1 (en) 1998-02-27 1999-02-25 N-sulphonyl and n-sulphinyl phenylglycinamide
AU30302/99A AU3030299A (en) 1998-02-27 1999-02-25 N-sulphonyl and n-sulphinyl phenylglycinamide
HU0101041A HUP0101041A3 (en) 1998-02-27 1999-02-25 Fungicidal n-sulphonyl and n-sulphinyl phenylglycinamide, intermediates, preparation and use thereof
CA002320838A CA2320838A1 (en) 1998-02-27 1999-02-25 N-sulphonyl and n-sulphinyl phenylglycinamide___________________
DE69905027T DE69905027T2 (en) 1998-02-27 1999-02-25 N-SULPHONYL AND N-SULPHINYL PHENYLGLYCINAMIDES
PL99342620A PL342620A1 (en) 1998-02-27 1999-02-25 N-sulphonyl- and n-sulphinylphenylglycinamide
US09/623,160 US6391918B1 (en) 1998-02-27 1999-02-25 N-sulphonyl and N-sulphinyl phenylglycinamide
BRPI9909239-5A BR9909239B1 (en) 1998-02-27 1999-02-25 compound and process for its preparation, intermediate and process for its preparation, as well as method and composition for control and prevention of plant infestation by microorganisms.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9804265.8A GB9804265D0 (en) 1998-02-27 1998-02-27 Organic compounds
GB9804265.8 1998-02-27

Publications (1)

Publication Number Publication Date
WO1999043644A1 true WO1999043644A1 (en) 1999-09-02

Family

ID=10827756

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/001216 WO1999043644A1 (en) 1998-02-27 1999-02-25 N-sulphonyl and n-sulphinyl phenylglycinamide___________________

Country Status (21)

Country Link
US (1) US6391918B1 (en)
EP (1) EP1071660B1 (en)
JP (1) JP2002504536A (en)
KR (1) KR100633719B1 (en)
CN (1) CN1226284C (en)
AR (1) AR018123A1 (en)
AT (1) ATE231489T1 (en)
AU (1) AU3030299A (en)
BR (1) BR9909239B1 (en)
CA (1) CA2320838A1 (en)
CR (1) CR5971A (en)
DE (1) DE69905027T2 (en)
ES (1) ES2191422T3 (en)
GB (1) GB9804265D0 (en)
GT (1) GT199900024A (en)
HU (1) HUP0101041A3 (en)
PL (1) PL342620A1 (en)
TR (1) TR200002485T2 (en)
TW (1) TW583162B (en)
WO (1) WO1999043644A1 (en)
ZA (1) ZA991575B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032569A2 (en) * 1998-12-03 2000-06-08 Syngenta Participations Ag Alpha-sulfin- and alpha-sulfonamino acid amides
WO2001087822A1 (en) * 2000-05-17 2001-11-22 Syngenta Participations Ag Novel phenyl-propargylether derivatives
WO2002021918A1 (en) * 2000-09-12 2002-03-21 Syngenta Participations Ag Fungicidal compositions
WO2005021490A2 (en) * 2003-08-29 2005-03-10 Syngenta Participations Ag N-SULFONYL-α-AMINO-ACID DERIVATIVES
JP2006298785A (en) * 2005-04-18 2006-11-02 Mitsui Chemicals Inc Diamine derivative, its manufacturing method and bactericide having the same as active ingredient

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068416A1 (en) * 2003-12-12 2005-07-28 Sumitomo Chemical Company, Limited Amide compound and method for controlling plant disease using same
GB0516705D0 (en) * 2005-08-15 2005-09-21 Syngenta Participations Ag Process
CN113649067B (en) * 2021-08-13 2023-08-11 万华化学(四川)有限公司 Organic photocatalyst, preparation method and application thereof in synthesis of 2,3, 5-trimethylhydroquinone diester

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0493683A1 (en) * 1990-12-20 1992-07-08 American Cyanamid Company Fungicidal amino acid amides
WO1995030651A1 (en) * 1994-05-04 1995-11-16 Ciba-Geigy Ag N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
WO1998038160A1 (en) * 1997-02-25 1998-09-03 Novartis Ag N-sulphonyl and n-sulphinyl amino acid amides as microbicides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221888B1 (en) * 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0493683A1 (en) * 1990-12-20 1992-07-08 American Cyanamid Company Fungicidal amino acid amides
WO1995030651A1 (en) * 1994-05-04 1995-11-16 Ciba-Geigy Ag N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
WO1998038160A1 (en) * 1997-02-25 1998-09-03 Novartis Ag N-sulphonyl and n-sulphinyl amino acid amides as microbicides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLARK, C.R. ET AL.: "Diastereoisomeric Derivatization and Liquid Chromatographic Analysis of N-(Phenylsulfonyl)-2-phenylglycine Aldose Reductase Inhibitors", JOURNAL OF CHROMATOGRAPHIC SCIENCE, vol. 28, no. 8, August 1990 (1990-08-01), pages 407 - 412, XP002106164 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032569A2 (en) * 1998-12-03 2000-06-08 Syngenta Participations Ag Alpha-sulfin- and alpha-sulfonamino acid amides
WO2000032569A3 (en) * 1998-12-03 2000-10-05 Novartis Ag Alpha-sulfin- and alpha-sulfonamino acid amides
US6538159B2 (en) 1998-12-03 2003-03-25 Syngenta Participations Ag α-sulfin-and α-sulfonamino acid amides
WO2001087822A1 (en) * 2000-05-17 2001-11-22 Syngenta Participations Ag Novel phenyl-propargylether derivatives
US6683211B1 (en) 2000-05-17 2004-01-27 Syngenta Crop Protection, Inc. Phenyl-propargylether derivatives
AP1601A (en) * 2000-05-17 2006-04-28 Syngenta Participations Ag Novel phenyl-propargylether derivatives.
KR100713575B1 (en) * 2000-05-17 2007-05-02 신젠타 파티서페이션즈 아게 Phenyl-propargylether derivatives
WO2002021918A1 (en) * 2000-09-12 2002-03-21 Syngenta Participations Ag Fungicidal compositions
WO2005021490A2 (en) * 2003-08-29 2005-03-10 Syngenta Participations Ag N-SULFONYL-α-AMINO-ACID DERIVATIVES
WO2005021490A3 (en) * 2003-08-29 2005-05-12 Syngenta Participations Ag N-SULFONYL-α-AMINO-ACID DERIVATIVES
US7884103B2 (en) 2003-08-29 2011-02-08 Syngenta Crop Protection, Inc. N-sulfonyl-α-amino-acid derivatives
JP2006298785A (en) * 2005-04-18 2006-11-02 Mitsui Chemicals Inc Diamine derivative, its manufacturing method and bactericide having the same as active ingredient

Also Published As

Publication number Publication date
ES2191422T3 (en) 2003-09-01
EP1071660B1 (en) 2003-01-22
US6391918B1 (en) 2002-05-21
KR100633719B1 (en) 2006-10-16
DE69905027T2 (en) 2003-10-09
GB9804265D0 (en) 1998-04-22
CN1291973A (en) 2001-04-18
ATE231489T1 (en) 2003-02-15
HUP0101041A3 (en) 2002-03-28
TW583162B (en) 2004-04-11
TR200002485T2 (en) 2001-01-22
CA2320838A1 (en) 1999-09-02
PL342620A1 (en) 2001-06-18
KR20010041345A (en) 2001-05-15
HUP0101041A2 (en) 2001-07-30
BR9909239B1 (en) 2010-07-13
BR9909239A (en) 2000-11-14
DE69905027D1 (en) 2003-02-27
CN1226284C (en) 2005-11-09
GT199900024A (en) 2000-08-18
AR018123A1 (en) 2001-10-31
CR5971A (en) 2000-01-05
EP1071660A1 (en) 2001-01-31
AU3030299A (en) 1999-09-15
ZA991575B (en) 1999-08-27
JP2002504536A (en) 2002-02-12

Similar Documents

Publication Publication Date Title
US6683211B1 (en) Phenyl-propargylether derivatives
AU2001260301A1 (en) Novel phenyl-propargylether derivatives
US6469005B1 (en) Propargylether derivatives
CN1311774A (en) trifuoro methylpyrrol carboxamides
EP1003719B1 (en) Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
US6391918B1 (en) N-sulphonyl and N-sulphinyl phenylglycinamide
WO1999032464A1 (en) Thiazole-, isothiazole- and thiadiazole-derivatives having microbicidal and plant immunizing activities
WO2003041728A9 (en) Novel phenyl-propargylether derivatives
EP0968179B1 (en) N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
EP0858448B1 (en) N-sulphonyl and n-sulphinyl amino acid derivatives as microbicides
US6194463B1 (en) N-sulphonyl and N-sulphinyl amino acid amides as microbicides
ES2536973T3 (en) Phenethylamide derivatives of alpha-oxygenated carboxylic acid
US6479550B1 (en) α-sulfenimino acid derivatives
US7700522B2 (en) α-Oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
MXPA00008383A (en) N-sulphonyl and n-sulphinyl phenylglycinamide___________________
US6538016B2 (en) α-sulfin-and α-sulfonamino acid amides
KR20020091199A (en) Novel α-sulfin- and α-sulfonamino acid amide derivatives

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 1200000775

Country of ref document: VN

Ref document number: 99803332.4

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1999911707

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 30302/99

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2320838

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000/02485

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/008383

Country of ref document: MX

Ref document number: 1020007009458

Country of ref document: KR

Ref document number: 09623160

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2320838

Country of ref document: CA

Kind code of ref document: A

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999911707

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020007009458

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1999911707

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1020007009458

Country of ref document: KR